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Overview 
Department of Health (2010) guidelines highlight the importance of diagnosis for adults 
with autism spectrum disorders (ASD) who have not previously had their condition 
recognised. Reliable, valid and user-friendly diagnostic tools must therefore be available.  
Part 1: This section critically appraises and systematically reviews 12 studies examining 
the NICE (2012) recommended adult ASD diagnostic tools. It concludes that there is 
good evidence to support the use of the Ritvo Asperger Diagnostic Scale-Revised 
(RAADS-R) and Autism Diagnostic Observation Schedule (ADOS), with some support 
for the use of the Autism Diagnostic Interview-Revised (ADI-R). However the Adult 
Asperger Assessment (AAA), Asperger Syndrome Diagnostic Interview (ASDI) and 
Diagnostic Interview for Social and Communication Disorders (DISCO) appear to have 
insufficient evidence at present. Further research is indicated for all the instruments. 
Part 2: This section presents a study of a new informant report diagnostic tool, the 
Developmental, Diagnostic and Dimensional Interview - Short Form Adult Version 
(3Di-sva). The 3Di-sva interview was completed with an informant for 27 ASD and 27 
non-clinical comparison participants. It demonstrated good psychometric properties, 
including good internal consistency and inter-rater reliability, and strong sensitivity and 
specificity.  The 3Di-sva is a time and cost-efficient tool, which could be suitable for use 
as part of a multi-dimensional adult ASD assessment. The study was completed as part 
of a joint project with McKenner (2015), who examined the 3Di-sva when used in a 
clinical comparison population. 
Part 3: This section is a critical appraisal which reflects upon areas relevant to both the 
literature review and empirical paper. The main focus of the discussion is upon on the 
idea of ideal versus achievable research and upon my learning process about research 
within NHS settings. 
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Abstract 
Aims. It is necessary to increase our understanding of the best methods of diagnosing 
autism spectrum disorders (ASD) in adults, in order to improve adult diagnostic services. 
This paper systematically identified and reviewed papers examining the psychometric 
properties of the NICE-recommended adult ASD diagnostic assessment tools – the Adult 
Asperger Assessment (AAA), Autism Diagnostic Interview-Revised (ADI-R), Autism 
Diagnostic Observation Schedule (ADOS), Asperger Syndrome Diagnostic Interview 
(ASDI), Diagnostic Interview for Social and Communication Disorders (DISCO) and the 
Ritvo Asperger Diagnostic Scale-Revised (RAADS-R). 
Method. PsychInfo and Medline were searched to identify relevant papers. A total of 
415 papers were found, of which 12 met criteria for inclusion. The quality of each paper 
was systematically evaluated using an adapted version of the BMJ Clinical Evidence 
(2014) tool. Measures of reliability and validity for each of the tools were examined and 
compared.  
Results. The RAADS-R and ADOS were found have the best quality evidence available 
for their use, whilst the ASDI and AAA had the poorest quality evidence. Where 
reported, measures of reliability were generally good; however overall there was a lack 
of reporting of reliability information, particularly for the AAA and ADI-R. Overall 
sensitivity and specificity was high across the measures, with the exception of the 
specificity of the DISCO. 
Conclusions. The review provides support for the use of the RAADS-R and the ADOS, 
and some support for the use of the ADI-R. It considered the evidence for the AAA, 
ASDI and DISCO insufficient at present to provide support for their current use in 
diagnosing adults. Further research is indicated for all the tools, particularly the 
informant report instruments.  
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Introduction 
Overview 
There has been a great deal of research on the diagnosis of Autism Spectrum 
Disorders (ASD) in children; however the diagnosis of ASD in adults has received 
less attention. Some individuals with ASD reach adulthood without receiving a 
diagnosis and it is therefore important that there are reliable, valid and user-friendly 
tools available for making a diagnosis in adults. Current NICE recommendations 
advise the use of at least one tool from a list of six when assessing adults for ASD 
(NICE, 2012). This review will examine the existing literature concerning the NICE 
recommended tools, in order to progress our understanding of the best methods of 
diagnosing ASD in adults.   
Autism spectrum disorders 
Autism spectrum disorders (ASD) are conceptualised as conditions in which 
two groups of symptoms are observed: social communication and interaction 
difficulties, and restricted and repetitive behaviours (DSM-5; American Psychiatric 
Association, 2013). Symptoms must begin in early childhood although they may not 
be recognised until later in life, and must cause functional impairment. ASD is a new 
diagnostic entity described in DSM-5 (APA, 2013) that subsumes previous separate 
categories of diagnosis such as autism, Aspergers, and atypical autism previously 
described in DSM-IV (APA, 2000). The prevalence of ASD among UK children has 
been found to be 157 per 10,000 children, with the ratio of known to unknown cases 
estimated at 3:2 respectively (Baron-Cohen et al., 2009). Therefore a high number of 
cases of childhood ASD go undetected, yet it has been shown that children with ASD 
do not grow out of the condition (Howlin & Moss, 2012).  The estimated occurrence 
 
 
12 
 
of ASD within community adult populations in England is similar to that reported for 
children (Brugha et al., 2011), with the prevalence of undiagnosed adults with autism 
reportedly being around 1% (Brugha et al., 2009). Ritvo, Ritvo, Freeman & Mason-
Brothers (1994) suggested that individuals with mild or late-appearing symptoms 
were less likely to come to clinical attention until adolescence or adulthood.  
Following the Autism Act 2009, the government set out a Strategy for Adults 
with Autism in England (Department of Health, 2010) with the aim of improving the 
lives of adults with ASD. Several key actions were stated, including development of 
local autism teams, planning and commissioning of autism services, and improving 
access to diagnosis and post-diagnostic support. This document highlights the 
importance of diagnosis for adults who have previously not had their condition 
recognised, and points out that the capacity for diagnosis must be increased. 
Similarly, recent NICE guidelines on autism in adults (NICE, 2012) note that there is 
wide variation in rates of identification and diagnostic practice for adults with 
features of autism, which lead to delays in diagnosis and access to appropriate 
services. The guidelines highlight the importance of a clear and consistent care 
pathway to diagnosis and aftercare for adults with ASD. 
Diagnostic tools for adults 
It is therefore important that good quality psychometric tools to assess and 
diagnose ASD in adulthood are available. However, many of the instruments 
currently used for the assessment of ASD are focused on toddlers and children and 
there is a lack of well validated diagnostic instruments suitable for use with adults. 
NICE guidelines (2012) recommend that for complex diagnosis and assessment of 
adults without learning disabilities, the following formal assessment tools are 
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considered: the Adult Asperger Assessment (AAA; Baron-Cohen et al., 2005), the 
Autism Diagnostic Interview-Revised (ADI-R; Lord et al., 1997), the Autism 
Diagnostic Observation Schedule – Generic (ADOS-G; Lord et al., 2000), the 
Asperger Syndrome (and high-functioning autism) Diagnostic Interview (ASDI; 
Gillberg et al., 2001), and the Ritvo Asperger Diagnostic Scale-Revised (RAADS-R; 
Ritvo et al., 2011). For adults with learning disabilities they suggest the ADOS-G 
and ADI-R. Additionally, the guidelines suggest that the ADOS-G, ADI-R or 
Diagnostic Interview for Social and Communication Disorders (DISCO; Wing et al., 
2002) are used to organise and structure the process of complex assessment of ASD 
in adults.  
Although some evidence is available suggesting that these tools are suitable 
for use with adults, the research in this area is limited. Thus far there has been little 
scrutiny of the existing research or comparison of the available evidence. It is 
important to increase our understanding of the best methods of diagnosing ASD in 
adulthood to enable the improvement of diagnostic services for adults with suspected 
ASD. We need to identify whether new tools need to be developed and where 
existing tools require updating and improving. 
Aim of this review 
The aims of this literature review are as follows:  
1. To systematically identify and review all published research papers 
examining the psychometric properties of the NICE-recommended adult ASD 
diagnostic assessment tools. 
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2. To carry out a detailed review of the methodological quality of each study 
examining the NICE-recommended adult ASD diagnostic assessment tools 
based upon a formal and systemic evaluation using a critical appraisal tool. 
The NICE (2012) guidelines are based upon a review of the psychometric 
properties of each tool, examined in a subsection of a review conducted in 2011 by 
the National Collaborating Centre for Mental Health (NCCMH; 2012). Some 
important and good quality research has been published more recently, such as a new 
paper examining a revised algorithm for Module 4 of the updated ADOS (Hus & 
Lord, 2014). This review will therefore update that that by NCCMH (2012) by 
searching for additional research published since this time. It will also include the 
first detailed review of study quality in the papers examining the recommended tools, 
which will be formally and systematically evaluated using a critical appraisal tool. 
This is designed to advance current understanding of the best methods of diagnosing 
ASD in adults.  
As no papers reviewing the DISCO when used in an adult population were 
available when the NICE (2012) guidelines were established, the DISCO was 
recommended as a tool to ‘organise and structure the diagnostic process’ rather than 
specified as a diagnostic tool. The DISCO will be included here in order to find and 
review any research that has been published since the guidelines were issued. 
Method 
Inclusion and exclusion criteria 
The inclusion criteria for the review were: 
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1. The study gives details on the psychometric properties of one of the six tools 
recommended for ASD diagnostic assessments as listed in the NICE 
guidelines (AAA, ADI-R, ADOS, ASDI, RAADS-R, or DISCO). 
2. The study offers information on the instrument’s ability to distinguish ASD 
from non-ASD. 
3. The mean age of the participants included in the study is at least 18. 
Exclusion criteria for the review were: 
1. The aim of the study is purely to look at the factor structure of the instrument. 
Search strategy 
Studies were identified from searches up to September 2014 in two electronic 
databases: PsychInfo and Medline. The first concept for the search was ‘Autism’ and 
the following text words were used to identify autism and combined using OR:  
i. autis* 
ii. ASD 
iii. Asperger* 
iv. Pervasive developmental disorder 
v. PDD 
Within PsychInfo the subject heading “Pervasive developmental disorders”, 
which included autism spectrum disorders was selected and combined with the text 
words using OR. Within Medline, due to the differences in subject heading options, 
the subject headings “child developmental disorders, pervasive/ or Asperger 
syndrome/ or autistic disorder” were combined with the text words using OR. 
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The second concept for the search was ‘NICE recommended adult ASD 
diagnostic tools’. These were searched for using the names of each tool. The 
following text words were therefore used to identify the tools and combined using 
OR: 
i. Adult Asperger assessment 
ii. AAA 
iii. Autism diagnostic interview* 
iv. ADI* 
v. Autism diagnostic observation schedule 
vi. ADOS* 
vii. Asperger syndrome diagnostic interview 
viii. ASDI 
ix. Ritvo autism Asperger diagnostic scale* 
x. RAADS* 
xi. Diagnostic interview for social communication disorders 
xii. DISCO 
Within PsychInfo, the above search for the diagnostic tool text words was 
limited to words within the following four areas: 1) title, 2) abstract, 3) key concepts, 
and 4) subject headings. Within Medline, due to differences in the options, the search 
for the diagnostic tool text words was limited to words within the following six 
areas: 1) title, 2) abstract, 3) keyword heading, 4) keyword heading word, 5) MESH 
subject heading, and 6) subject heading word. The text word search was limited to 
these areas in order to reduce the irrelevant papers to a manageable number to search 
through. Without these limits an excess of papers were found listing the diagnostic 
tools as measures used within the research but not examining the measure itself.  
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The text words for autism and the NICE recommended measures were 
combined using AND. The searches were limited to human, English language, peer 
reviewed journals, and adulthood. In order to identify any additional relevant papers, 
the reference lists of the final selected papers were examined and the citation tool on 
Google Scholar was checked. 
Identification of relevant papers from search results 
The search of PsychInfo yielded a total of 415 papers. The papers were all 
examined for relevance based on the title and abstract. Papers were initially 
disregarded on the basis that they had clearly not examined the psychometric 
properties of any of the included ASD measures. This left 45 papers, of which a 
further 13 were disregarded as they included only children as participants. Full 
manuscripts were obtained for the remaining 32 studies. Of these 12 were found to 
meet the inclusion criteria. No additional papers were found following the search on 
Medline, or from examining the reference lists or Google Scholar citations. This 
search revealed no other previous reviews of the tools to diagnose ASD in adults. See 
Figure 1 for flow diagram of search outcome. 
It should be noted that two studies did not include a mean age of the 
participants and it cannot therefore be confirmed that the mean age was over 18 
years. One study on the ADOS module 4 (Brugha et al., 2012) was certain to have a 
mean age over 18 as it included 618 adults over age 16, and participants were 
grouped by age with high numbers of participants included in older age groups 
including up to >75 years. The study on the ASDI (Gillberg et al., 2001) is less 
certain to have had a sample with a mean age over 18 as it included just 24 
individuals aged 6-55 and no indication of the distribution of these ages is given. The 
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study is included as it is the only study examining the ASDI, however the results of 
this paper in must be interpreted with caution with regards to its use with adults.  
 
 
 
 
 
 
 
 
 
Analysis of study quality 
The quality of each study was systematically analysed using the BMJ Clinical 
Evidence (2014) tool for critically appraising diagnostic test studies. The tool was 
adapted slightly to optimise it for use with the ASD diagnostic studies under 
consideration in this review. See Appendix 1 for a copy of the adapted tool used, 
including notes about how it was administered for the purpose of this review. The 
changes made to the tool include: 
1. The addition of a question on sample size. This was set as a sample of at least 
20 ASD vs 20 non-ASD participants. This sample size was chosen in order to 
differentiate those studies using particularly small samples from the rest. 
Excluded, n=20: 
Mean age of sample was 
under 18, n=15 
Not about psychometric 
properties of tool, n=4 
About factor structure of 
measure only, n=1 
Papers identified from 
databases, n=415 
Papers identified from 
other sources, n=0 
Papers screened, n=415 
Removed as not about 
psychometric properties of 
tool or clearly only included 
children as participants: 
n=370 
Full papers obtained, 
n=32 
Papers included in 
review, n=12 
Figure 1. Database search outcome 
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2. The addition of a question on whether cognitive ability was examined. This is 
because differing cognitive ability is a potential confound if not examined 
and controlled for. 
3. Removal of a section of three questions focusing on applying the diagnostic 
test to a specific patient. The questions removed were: ‘Is the patient similar 
to the people in the study in terms of clinical and demographic 
characteristics?’, ‘Is the diagnostic test available and if so does it reflect 
current practice?’, and ‘Will the results change the way the patient is 
managed?’. These questions are not relevant in this case as we are not 
looking to apply the instruments to a specific patient at this time. 
4. The addition of a list of important psychometrics, to identify which of these 
were reported by the study. Studies were scored according to whether they 
provided detail on inter-rater reliability, test-retest reliability, internal 
consistency, convergent validity, and any correlation between score on the 
tool and participant characteristics such as age. 
Each study was examined and scored a 1 for a ‘yes’ and 0 for a ‘no’ or 
‘unclear’ answer. Studies were also awarded a score of 0.5 on certain items if they 
partially fulfilled the criteria. A table showing how each paper was scored is 
displayed in Appendix 2. 
Results 
The key characteristics of the 12 papers included are presented in Table 1. Of 
these studies four included the ADOS module 4, three the RAADS/RAADS-R, two 
the ADI/ADI-R, and there was one on each of the AAA, the ASDI, and the DISCO. 
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There was also one paper on both the ADI-R and the ADOS specifically for use with 
adults with learning disabilities.  
The key features of each NICE recommended ASD diagnostic assessment 
tools are provided in Table 2. 
Of the 12 papers retrieved, seven were the same as those included in the 
NCCMH (2012) review (Baron-Cohen et al., 2005, Brugha et al., 2012, Gillberg et 
al., 2001, Lord et al., 1997, Lord et al., 2000, Ritvo et al., 2008, Ritvo et al., 2011, 
and Sappok et al., 2013). Therefore the current literature search retrieved five 
additional relevant studies not included in those reviewed for the NICE guidelines 
(NCCMH, 2012). 
The additional papers include one on the RAADS-R (Anderson et al., 2011), 
two on the ADOS module 4 (Bastiaansen et al., 2011, Hus & Lord, 2014), and one 
on the DISCO and ADI-R (Ngyren et al., 2009). Only one of these has been 
published since the NICE guidelines were published. On review of the search 
strategy for the NCCMH (2012) review it is apparent that Anderson et al. (2011) and 
Nygren et al. (2009) may not have been included as they examine Swedish 
translation versions of the instruments. It is unclear as to why the Bastiaansen et al. 
(2011) paper was not retrieved. It was decided that it was helpful to include the two 
Swedish translation studies as this broadens the evidence base regarding usefulness 
of the measures. Additionally, there are no papers published on the DISCO for use 
with adults other than this Swedish translation version.
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Table 1  
Study characteristics 
    
Study Tool Participants Study design & 
recruitment 
Country Diagnosis of ASD Procedure 
Anderson et 
al. (2011) 
RAADS-
R 
(Swedish 
version) 
75 ASD aged 26-62 (M= 
31; M:F = 36:35) 
 
197 non-ASD aged 19-75 
(M= 34; M:F = 80:116) 
 
Case-control 
 
Recruited from multiple 
sites including clinics 
(ASD) and universities 
(comparison). 
 
Sweden Confirmed by 
either positive 
ADOS-G or 
DISCO 
All participants completed 
RAADS-R. Subset of both 
groups completed AQ. 
Baron-Cohen, 
Wheelwright, 
Robinson, & 
Woodbury-
Smith (2005) 
 
AAA 42 ‘patients’ (age range 
not reported but M = 34.1; 
M:F = 36:6) 
 
Cohort 
 
Patients attending one 
diagnostic clinic for 
adults with suspected 
ASD. 
England Based on clinician 
judgement of 
meeting DSM-IV 
criteria (including 
using information 
gathered from 
AAA) 
 
All participants completed the 
AAA. AAA score was 
compared to diagnosis based 
on meeting DSM-IV criteria. 
 
 
Bastiaansen et 
al. (2011) 
ADOS 
module 4 
38 ASD aged 18-66 (M= 
31.82) 
 
18 Schizophrenia aged 19-
61 (M= 37) 
 
16 Psychopathy aged 23-
60 (M= 39) 
 
21 non-clinical controls 
aged 21-53 (M= 34.23) 
 
Males only 
Case-control 
 
Recruited from multiple 
sites including mental 
health organisations and 
clinics. 
Netherlands According to DSM-
IV-TVR criteria 
based on review of 
developmental 
history, current 
daily functioning 
and observation. 
All participants completed the 
ADOS module 4, completing 
all the standard activities and 
optional daily living items. 
 
IQ estimated for all except for 
nine participants using GIT2 
(n= 80) or WAIS (n=4) 
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Brugha et al. 
(2012) 
ADOS 
module 4 
618 adults over age 16 
(M:F = 344: 366). Mean 
age not stated. 
Cohort 
 
Community sample of 
adults randomly selected 
from general population. 
England Confirmed using 
either DISCO and 
ADI-R, or clinical 
consensus based on 
vignettes 
containing record 
of ADOS, AQ-20, 
and clinical 
interview. 
 
Participants completed AQ and 
ADOS module 4. Subset of 
sample completed DISCO and 
ADI-R (n=56). 
Gillberg, 
Gillberg, 
Rastam & 
Wentz (2001) 
ASDI 24 individuals aged 6-55 
(M:F = 18:6). Mean age 
not stated. 
 
17 neuropsychiatric 
disorder (10 AS, 3 
atypical autism, 2 OCD, 2 
ADHD, 1 MPD) 
 
7 non-clinical controls. 
 
Cohort 
 
Recruitment site 
information not stated. 
 
Sweden Based on consensus 
between two 
neuropsychologists, 
based Gillberg and 
Gillberg (1989) 
criteria for 
Asperger 
syndrome. 
 
Informants who knew the 
participants well (including 
when they were children) 
completed the ASDI. 
Hus & Lord 
(2014) 
ADOS 
module 4 
– new 
algorithm 
177 autism aged 10-55 
(M= 20.12) 
 
170 other-ASD aged 9-54 
(M= 21.14) 
 
90 non-ASD (84% 
clinical, 16% non-clinical) 
aged 13-62 (M= 25.17) 
 
Participant sex not stated. 
Case control 
 
Recruited from multiple 
sites – research studies 
and clinic referrals.  
USA Varied according to 
site but based on 
best estimate 
clinical diagnoses 
based on DSM-IV-
TVR criteria. 
Varied according to site but all 
participants completed ADOS 
module 4. 
 
IQ estimated for 91% of 
participants using various 
validated IQ measures, most 
commonly WASI or DAS. 
 
 
23 
 
Lord et al. 
(1997) 
ADI/ 
ADI-R 
60 autism aged 12-40 (M= 
21.4) 
 
36 non-autism comparison 
(including clinical cases)  
aged 7-38 (M= 17.5) 
 
M:F distribution not 
reported. Adult subset of 
sample reported here.  
 
Cohort 
 
Recruited from multiple 
sites, mainly based at 
universities. 
 
England, 
USA, France  
Clinical judgement 
of principal 
investigator/ senior 
research associates 
using Rutter (1978) 
criteria. 
ADI/ADI-R interview 
conducted with informant for 
each participant.  
 
Non-verbal IQ estimated for 
majority of participants using 
variety of validated measures. 
Lord et al. 
(2000) 
ADOS 
module 4 
16 Autism (M age= 18.65; 
M:F= 14:2) 
 
14 PDDNOS (M age= 
21.59; M:F= 11:3) 
 
15 Non-ASD comparison 
(clinical and non-clinical) 
(M age= 19.11; M:F= 
12:3) 
 
Overall age range: 10-40 
 
Case control (all matched 
on verbal IQ) 
 
Recruited from referrals 
to a developmental 
disorders clinic (ASD) 
and other clinics/groups 
(comparison) 
 
USA Consensus clinical 
diagnosis based on 
clinical impression 
from history, 
physical 
examination, and 
ADI-R score. 
All participants completed 
ADOS-G module 4. 
 
Verbal and non-verbal IQ 
estimated for all participants 
using variety of validated 
measures. 
Nygren et al. 
(2009) 
DISCO 
and ADI-
R 
(Swedish 
version) 
27 ‘patients’ aged 15.2-
39.7 (M= 24.7; M:F= 
14:13). 
 
Only adult subset of larger 
sample reported here. 
 
 
Cohort 
 
Patients with suspected 
ASD referred to 
diagnostic clinic. 
Sweden Assigned at case 
conference. 
Diagnoses based on 
DSM-IV criteria, 
except Asperger 
diagnosis (based on 
Gillberg & Gillberg 
(1989) criteria). 
DISCO conducted with 
informant (close relative) for 
each participant. ADI-R also 
completed with subset of 
sample (n=21). 
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Notes: M = mean; M:F = number of male:female participants; AQ = Autism Quotient (Baron-Cohen et al., 2001); AS = Asperger Syndrome;  MPD = multiple personality 
disorder 
Ritvo et al. 
(2011) 
RAADS-
R 
66 Autism age 18+ (M= 
30.81; M:F= 52:14)  
 
135 Asperger age 18+ 
(M= 32.01; M:F= 93:42) 
  
276 no previous DSM-IV-
TR diagnosis age 18+ 
(M=41.52; M:F= 114:162) 
 
302 DSM- IV-TR axis I 
diagnosis other than ASD 
age 18+ (M=42.04; M:F= 
134:168) 
 
Case-control 
 
Recruited from multiple 
research sites with 
ongoing clinical and 
research programmes 
focussing on autism. 
 
USA, 
Canada, 
England, 
Australia 
Diagnoses based on 
DSM-IV-TR 
criteria, plus meet 
criteria on ADOS 
module 4 or ADI 
and ADOS.  
Varied according to site but 
included diagnostic and IQ 
screening, all participants 
completed RAADS-R in 
presence of clinician. 
Ritvo et al. 
(2008) 
RAADS 37 ASD aged 18-65 
(M=35; M:F= 22:15) 
 
57 comparison (inc DSM-
IV-TR axis 1 diagnosis 
and no diagnosis) aged 
18-65 (M= 41; M:F= 
25:32) 
 
Case-control 
 
Recruited from multiple 
sites including clinics and 
universities. 
 
USA Diagnosis by two 
clinicians using 
DSM-IV-TR 
criteria. 
All participants completed 
RAADS-R in presence of 
clinician. 
Sappok et al. 
(2013) 
ADOS / 
ADI-R 
55 ASD aged 18+ (M=36; 
M:F= 42:13) 
 
24 non-ASD aged 18+ 
(M=35; M:F= 17:7) 
Cohort 
 
Referrals to a hospital 
specialising in learning 
disabilities. 
Germany Made by team of 
professionals in 
case conference, 
based on ICD-10 
criteria. 
Where possible participants 
completed the ADOS (module 
dependent on participant) and 
ADI-R. ADOS – 68% feasible 
to test. ADI-R – 37% feasible 
to test 
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Table 2  
Measure characteristics 
Measure Main charactaristics How administered Time to complete Designed for/as Availability and 
training 
AAA 4 sections each describing a 
group of symptoms (social 
interaction, restricted and 
repetitive behaviour, verbal/non-
verbal communication and 
imagination) and a final section 
of 5 prerequisites 
 
Uses data from AQ and EQ 
screening questionnaires 
 
Electronic, data-based, 
computer scored, 
clinician administered 
 
Completed by person 
with suspected ASD, 
and informant (for 
developmental history) 
 
Takes around 3 hours 
(including feedback on 
diagnosis) 
Specifically for adults 
(of normal intelligence) 
 
To be used as a 
complete diagnostic 
system 
 
Freely available 
 
Unclear if training 
needed 
 
ADI-R 93 items arranged in three 
functional domains: 
language/communication, 
reciprocal social interactions, 
restricted repetitive and 
stereotyped behaviours and 
interests. 
 
Standardized clinician-
based interviews 
 
Completed with 
informant who knows 
person and knew them 
as a child 
 
90 – 150 minutes 
including scoring 
For children and adults. 
Most studies examine 
properties of measure 
using child samples. 
 
Revised version of 
ADI 
Available to buy 
 
Requires extensive 
training and practice in 
the administration and 
scoring. 
 
 
ADOS (module 
4) 
Semi-structured assessment of 
social imagination, 
communication, play, and 
imaginative use of materials 
 
Consists of 10-15 activities with 
31 accompanying ratings. 
 
Clinician administered 
observation tool 
 
Completed with person 
with suspected ASD 
Around 45 minutes For adults with fluent 
use of language 
 
A clinical adjunct 
diagnostic tool (no 
developmental history 
acquired or information 
about functioning in 
other contexts) 
Available to buy 
 
Requires extensive 
training and practice in 
the administration, 
observation and 
scoring.  
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ASDI 20 items covering 6 different 
areas (reciprocal social 
interaction, narrow interest 
patterns, routines rituals and 
interests, speech and language 
peculiarities, non-verbal 
communication, motor 
clumsiness 
 
Clinician administered 
interview 
 
Completed by 
informant who knows 
person and knew them 
as a child 
 
 
Around 10 minutes As an adjunct 
diagnostic tool for 
Asperger’s syndrome 
and high functioning 
autism in adults in 
accordance with 
Gillberg & Gillberg 
(1989) criteria 
 
Freely available 
 
No training required 
DISCO 362 items looking at 
developmental history and 
current behaviour. Examines 
skills, deficits and untypical 
behaviour. 
 
Semi-structured 
investigator-based 
interview 
 
Completed with 
informant who knows 
person and knew them 
as a child 
 
 
Not stated but 
interview is long 
(contains the most 
items of all measures 
examined) 
To understand person’s 
pattern of behaviour 
and needs as well as 
diagnosis 
 
To cover the broad 
autism spectrum at all 
ages (although most 
studies examine 
properties of measure 
using child samples). 
 
Available to buy 
 
Requires extensive 
training and practice in 
the administration and 
scoring. 
RAADS-R 80-item self-rating scale, four 
subscales: social interaction, 
language, circumscribed 
interests, sensory motor 
symptoms 
 
64 symptom based questions, 16 
non-symptom based responses 
 
Self-report but 
administered by a 
clinician in a clinical 
setting 
 
Completed by person 
with suspected ASD 
 
Around 30 minutes Specifically for adults 
(of normal intelligence) 
 
A clinical adjunct 
diagnostic tool 
 
Revised version of 
RAADS 
 
Freely available 
 
Unclear if training 
needed 
      
Notes: AQ = Autism Quotient (Baron-Cohen et al., 2001); EQ = Empathy Quotient (Baron-Cohen & Wheelright, 2004).
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Reliability 
Reliability refers to the reproducibility of the instrument, in other words how 
consistent the measure is and how prone it is to measuring random error (Barker, 
Pistrang & Elliott, 2002). Internal consistency, test-retest reliability and inter-rater 
reliability for each paper reviewed is displayed in Table 3 and described below. 
Although there are no absolute criteria against which to judge reliability, Barker et al. 
(2002) suggest that a figure of 0.8 or above is considered good reliability and 0.5 or 
below is considered poor reliability. They also propose that 0.7 is acceptable and 0.6 
is marginal reliability. 
Internal consistency 
Internal consistency is a measure of the inter-item reliability of a scale 
consisting of multiple similar items. It asks whether the different items do indeed 
relate to the same construct (Barker et al., 2002). Internal consistency was not 
reported in papers examining the AAA (Baron-Cohen et al., 2005), ASDI (Gillberg 
et al., 2001), DISCO (Nygren et al., 2009), or the ADI-R as used in non-LD 
populations (Lord et al., 1997, Nygren et al., 2009). One of the ADOS module 4 
papers did not report internal consistency figures (Brugha et al., 2012) and another 
reported internal consistency figures but not for module 4 (i.e. the adult population) 
separately from the other groups (Lord et al., 2000) meaning the relevant figures 
could not be established. 
For the RAADS-R, all subscales had acceptable or good internal consistency 
in the international study (Ritvo et al., 2011) and three out of the four subscales had 
acceptable or good internal consistency in the Swedish study (Anderson et al., 2011).  
The internal consistency of the language subscale in the Swedish translation of the 
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RAADS-R was poor (Anderson et al., 2011). Sappok et al., 2013 showed very good 
internal consistency for all ADOS modules when used in an LD population; however 
the internal consistency of the ADI-R when used in an LD population was low. 
Both of the papers reporting on the ADOS module 4 (Bastiaansen et al., 
2011, Hus & Lord, 2014) examined internal consistency of the social affect scale. 
This is a new domain suggested by Gotham, Risi, Pickles & Lord (2007) which 
reorganises and synthesises items from the two previous ADOS domains of social 
interaction and communication, in order to reflect the new DSM-5 criteria for ASD.  
Bastiaansen et al. (2011) also looked at the internal consistency of the pre-existing 
domains of social interaction and communication. Based on their work to revise and 
calibrate the module 4 algorithms, Hus and Lord (2014) also introduced another 
domain, the restricted and repetitive behaviour domain. In both studies the social 
affect scale showed good internal consistency. The restricted and repetitive 
behaviour subscale was acceptable. 
Test-retest reliability 
Test-retest reliability examines the consistency of a measure over time 
(Barker & Pistrang, 2002). Test-retest reliability was not reported in the majority of 
the papers. It was reported by the two RAADS-R papers (Anderson et al., 2011, 
Rivto et al., 2011). Anderson et al. (2011) examined test-retest reliability on a subset 
of 12 participants with a 3-6 month interval between completions of the measure. 
Ritvo et al. (2011) examined test-retest reliability on a subset of 30 participants, with 
a mean 1 year interval between completions of the measure. The figures show good 
test-retest reliability for the total scale in both cases. Only Anderson et al. (2011) 
reported figures for the subscales, which show acceptable or good test-retest 
 
 
29 
 
reliability for three of the four subscales, with the language subscale of this Swedish 
translation version being noticeably less reliable. The ASDI paper (Gillberg et al., 
2001) also examined test-retest reliability, by re-interviewing 20 participants at 10-15 
months after the first interview. They found good test-retest reliability. 
Inter-rater reliability 
Inter-rater reliability measures the degree of agreement between two different 
raters using the instrument. Reporting of inter-rater reliability was mixed; where 
applicable most papers made reference to inter-rater reliability, although many failed 
to report a kappa value, instead reporting only the percentage of agreement between 
raters, which is problematic as it does not correct for agreement due to chance. Inter-
rater reliability was mentioned in three of the ADOS module 4 papers. Bastiaansen et 
al. (2011) found acceptable inter-rater reliability for overall classification on the 
ADOS module 4. Lord et al. (2000) found that raters were in agreement on overall 
classification on the ADOS module 4 in 84% of cases and Hus & Lord (2014) 
reported that agreement was consistently above 75% throughout the study. Gillberg 
et al. (2001) reported very good inter-rater reliability on the ASDI. Nygren et al. 
(2009) did not report on inter-rater reliability for overall classification on the DISCO, 
however they demonstrated good agreement on the majority of items on the measure. 
Lord et al. (1997; ADI-R) and Brugha et al. (2009; ADOS module 4) did not 
examine inter-rater reliability for the cases included in the study but reported raters 
must have reached an agreement of at least 90% during training. It was not 
applicable to measure inter-rater reliability on the RAADS-R as this is self-rating 
measure.
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Table 3  
Reliability of each instrument 
Paper Internal consistency (Cronbach’s 
alpha, α) 
Test re-test reliability Inter-rater reliability 
AAA (Baron-Cohen et al, 
2005) 
 
Not reported Not reported Not reported 
ADI-R (Lord et al, 1997) Not reported Not reported 90% item by item agreement criteria 
before  study commenced (no kappa 
reported) 
 
ADI-R (Nygren et al, 2009) 
 
Not reported Not reported Not reported 
ADI-R (LD) (Sappok et al, 
2013) 
 
0.58 Not reported Not reported 
 
ADOS module 4 
(Bastiaansen et al, 2011) 
 
Social interaction, old algorithm: 0.84 
Communication, old algorithm: 0.60 
Social affect, revised algorithm: 0.87 
 
Not reported 
 
Overall classification: 89.2% agreement, 
kappa=0.73  
 
ADOS module 4 (Brugha et 
al, 2012) 
Not reported 
 
Not reported  90% item by item agreement before 
study commenced (no kappa reported) 
 
ADOS module 4 (Hus & 
Lord, 2014) 
 
Social affect: 0.84 
Restricted and repetitive behaviour: 
0.61 
 
 
Not reported 
 
80% initial item by item agreement. 
Consistently exceeded 75% item by item 
agreement (no kappa reported) 
ADOS module 4 (Lord et al, 
2000) 
 
Figures are mixed for all four modules 
(i.e. cannot separate adult sample) 
Figures are mixed for all four modules 
(i.e. cannot separate adult sample) 
Overall classification: 84% agreement 
(no kappa reported) 
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ADOS (LD) (Sappok et al, 
2013) 
 
Module 1: 0.81 
Module 2: 0.89 
Module 3: 0.93 
Module 4: 0.92  
Not reported 
 
 
Not reported 
 
ASDI (Gillberg et al, 2001) 
 
Not reported Reported as kappa= 0.92 (complete 
agreement on 97% of ratings) 
 
Kappa = 0.91 
 
DISCO (Nygren et al, 2009) Not reported 
 
Not reported 
 
 
 
Reported only for individual items. 
Kappa’s ranged from 0.35 to 0.91. 
Kappa’s for >90% items were over 0.60  
RAADS (Ritvo et al, 2008) 
 
Language and communication: 0.65 
Sensorimotor and stereotypies :0.73 
Social relatedness: 0.86 
 
Not reported 
 
Not applicable  
 
RAADS-R (Anderson et al, 
2011) 
 
 
ASD/comparison 
 
Total scale: 0.92/0.94  
Circumscribed interests: 0.73/0.73 
Language: 0.58/0.22 
Sensory motor: 0.81/0.77 
Social interaction: 0.87/0.89 
 
 
 
Total scale: r=0.80, p=0.002 
Circumscribed interests: r=0.73, p=0.002 
Language: r=0.43, p=0.161 
Sensory motor: r=0.84, p=0.001 
Social interaction: r=0.76, p=0.004 
 
 
 
Not applicable  
 
RAADS-R (Ritvo et al, 
2011) 
 
Circumscribed interests: 0.90 
Language: 0.79 
Sensory motor: 0.91 
Social relatedness: 0.92 
Total scale: r=0.987 (p not reported) 
 
Not applicable  
 
N.B. Green denotes good reliability (r>0.8) 
         Orange denotes acceptable reliability (r=0.6 – 0.79) 
         Red denotes poor reliability (r<0.59) 
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Validity 
Validity looks at whether an instrument measures what it is purported to 
measure. Criterion validity asks how well the instrument correlates with an indicator 
of the construct it is assessing (Barker et al., 2002). In this case it examines the 
degree of agreement between the measure and whether or not the person has ASD. 
Criterion validity for diagnostic measures is measured in terms of sensitivity and 
specificity. Sensitivity measures the accuracy of the instrument in picking out people 
who do have the condition (i.e. the number of true positives versus false negatives) 
and specificity measures  how well the instrument avoids picking up people who do 
not have the condition (i.e. the number of true negatives versus false positives). 
Criterion Validity: Sensitivity and specificity 
The sensitivity and specificity with respect to ASD diagnosis for each 
measure according to each paper reviewed is shown in Figure 2. In Figure 3, an 
overall sensitivity and specificity figure is shown for each measure, based on samples 
combined across studies. Sensitivity and specificity figures were reported in nine of 
the twelve papers reviewed. For the three papers in which these figures were not 
reported (Baron-Cohen et al., 2005, AAA; Gillberg et al., 2001, ASDI; Nygren et al., 
2009, DISCO and ADI-R), they were calculated using  figures given within the 
papers regarding numbers of correctly and incorrectly identified cases.  
Where figures for sensitivity and specificity were provided for both autism 
and ASD (Lord et al., 2000 and Sappok et al., 2013) the figures for ASD were used, 
based on the fact that under new DSM-5 criteria all autism related diagnoses are now 
classified as ASD. Where papers presented figures for existing algorithms versus 
revised algorithms (Bastiaansen et al., 2011; Hus & Lord, 2014; Sappok et al., 2013), 
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the figures for the revised algorithm were used based on the principle that these are 
the optimal algorithms for the measure. 
It can be seen that overall sensitivity and specificity was fairly high across the 
measures. The RAADS/-R demonstrates the highest overall levels of sensitivity and 
specificity.  The RAADS/-R and the ADOS module 4 demonstrate the smallest 
confidence intervals around their estimates of sensitivity and specificity, reflecting 
the large overall sample sizes of these studies. One measure that noticeably 
underperforms in terms of specificity is the DISCO (Nygren at al., 2009; specificity 
of 0.50). However it is worth noting that only 6 cases were used to calculate this 
figure meaning the validity of this figure may be questionable. When used in an LD 
population of adults, the ADOS also demonstrates lower specificity than many of the 
others (0.65; Sappok et al., 2013). Finally, the ADOS module 4 as reported by 
Bastiaansen et al. (2011) appears to show slightly lower sensitivity (0.71) and 
specificity (0.82) than many of the others. However these figures are still within an 
acceptable range and this study was one of the few to compare separate groups of 
adults with clinical diagnoses that may be confused for ASD, effectively making it a 
more stringent test of the measure than some of the others.  
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Figure 2. ASD diagnostic tool sensitivity and specificity by paper 
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Figure 3. Combined sensitivity and specificity for each ASD diagnostic tool 
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Study quality and methodological considerations 
The quality of each study was systematically analysed using the BMJ Clinical 
Evidence (2014) tool. Table 4 displays the studies in order of rank according to score 
using the critical appraisal tool. Table 5 displays an overall score and rank order for 
each tool, created by calculating the mean score for studies evaluating each tool. 
The RAADS/-R and ADOS both score highly, with the RAADS/-R being 
rated as tool with the best quality evidence for its use. They are followed by the ADI-
R and then the DISCO. The ASDI and AAA score lowest in terms of the quality of 
the evidence available for their use. It is interesting to note that the three lowest 
scoring measures have only one published paper each examining the tool when used 
with adults. 
 
  
 
 
 
 
 
 
 
Table 4  
Study ranking according to the modified BMJ Clinical 
Evidence score 
Study Score 
RAADS-R  (Ritvo et al, 2011) 20 
ADOS module 4 (Bastiaansen et al, 2011) 19.5 
ADOS (LD)  (Sappok et al, 2013) 18.5 
ADOS module 4  (Hus & Lord, 2014) 18 
RAADS-R  (Anderson et al, 2011) 18 
ADI-R (LD) (Sappok et al, 2013) 17.5 
ADOS module 4  (Lord et al, 2000) 17.5 
RAADS  (Ritvo et al, 2008) 16.5 
DISCO/ADI-R  (Nygren et al, 2009) 15.5 
ADI-R  (Lord et al, 1997) 14 
ASDI  (Gillberg et al, 2001) 13.5 
ADOS module 4 (Brugha et al, 2012) 12.5 
AAA  (Baron-Cohen et al, 2005) 10 
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The two studies which score lowest according to the critical appraisal are the 
AAA and the ASDI. Particular problems in the AAA paper (Baron-Cohen et al., 
2005) include the lack of an appropriate sample size (only 5 participants did not have 
ASD according to DSM-IV criteria or 8 participants according to the AAA), no 
comparison group of participants with other psychopathology that might be mistaken 
for ASD, lack of blinding of the assessor, no measure of cognitive ability of the 
participant, and lack of reporting of psychometric properties of the measure. Reasons 
the ASDI paper (Gillberg et al., 2001) scored low include the limited sample size (13 
participants with ASD and 11 participants without), lack of information about the 
study methodology such as participant details, and lack of reported estimate of 
diagnostic accuracy. The reason the DISCO (Nygren et al., 2009) scores lower than 
others include the lack of consideration of important psychometrics and a sample 
with only six non-ASD participants. 
Although the ADOS scores highly on the combined analysis, it is worth 
noting that Brugha et al. (2012) scored noticeably lower than other studies of this 
Table 5  
Overall ranking according to modified BMJ 
Critical Evidence tool 
Study Score 
RAADS/-R 18.17 
ADOS1 17.1 
ADI/-R1 15.67 
DISCO 15.5 
ASDI 13.5 
AAA 10 
Note. 1 Calculated including the papers examining 
instrument in both LD and non-LD populations. 
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measure. Reasons for the low scoring of this paper include lack of gold reference 
standard, no inclusion of a population with psychopathology similar to autism (i.e. a 
clinical control group), no measure of cognitive ability, inclusion of ADOS module 4 
record in vignettes used to make diagnosis and compare to ADOS module 4 results, 
and lack of some of the desired psychometrics. However, it should be considered that 
this study was unlike all the other validation studies considered, including the others 
on the ADOS module 4, in that it sought to validate it as a survey method for 
identifying cases of ASD among adults in the community. With such a vast sample 
(n=618) it may not have been feasible to measure cognitive ability, and in this case 
the inclusion of a clinical control population was not relevant. Although this study 
does not score highly on the BMJ Critical Appraisal tool, it is an important and 
unique validation of the ADOS module 4 that no other tools have received. 
Discussion 
Key findings 
The main findings of the review are summarised below for each instrument. 
This review has considered the psychometric properties of each diagnostic 
assessment tool and the quality of each study reviewed.  Although reliability, validity 
and study quality are the key concerns when comparing different instruments for 
diagnosing ASD in adults, other factors were also considered, such as how the 
instrument is administered and the availability and cost of the instrument. All of 
these aspects are considered when drawing conclusions about the overall value of 
each tool.  
It should be noted that the widely accepted gold standard for an ASD 
assessment involves information collected from multiple perspectives, such as direct 
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observation, informant report and self-report (Baird et al., 2006). The only tool 
reviewed here which collects information from more than one perspective is the 
AAA, which requires the person themselves to complete two questionnaires, the AQ 
and the EQ, and then asks questions of an informant. The other measures reviewed 
collect information from one source and are intended to be used as adjunct tools, as 
part of a multi-dimensional assessment. Although it may be advantageous to be able 
to reach a diagnostic conclusion with just one instrument in terms of time, effort and 
cost of the assessment, due to the complexity of making a diagnosis of ASD, 
particularly in an adult, triangulation of information from different tools and methods 
should be encouraged to reach the most reliable conclusion.   
Informant-based tools 
Using informant-based tools means information can be provided about the 
person during early childhood, which is key to making a diagnosis according to 
DSM-IV/DSM-5 criteria, which state that symptoms must begin in early childhood, 
as well as ICD-10 criteria which state that symptoms must begin before three years 
of age (World Health Organisation, 1992). However, informant-based tools can be 
problematic for an adult population, where an informant may not be available or it 
may be difficult for the informant to recall developmental information. Four 
informant-based interviews were considered here, the AAA (which also includes 
self-report information from the patient), the ADI-R, the ASDI and the DISCO.  
AAA 
The one study evaluating the AAA scored particularly low on the critical 
appraisal tool. The level of methodological concern about the study, including a lack 
of an appropriate sample size, blinding and measure of cognitive ability, is 
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significant and would suggest that its results should be treated as preliminary. As 
such, the current state of research on the AAA does not appear justify its 
recommendation for use by NICE (2012). Further more rigorous research is needed 
before it can confidently be recommended. It should be noted that although it 
demonstrated good sensitivity and specificity, there were no reliability data (such as 
internal consistency, test-retest reliability, or inter-rater reliability) reported for the 
AAA, meaning we have no knowledge about how consistently this instrument 
performs. Asides from the low critical appraisal score, it is difficult to advocate the 
use of a tool in which the reliability is currently unknown. The AAA does have 
potential to be a useful tool if future research was able to demonstrate sound 
psychometric properties, as it is freely available and does not appear to require 
extensive training, making it easily accessible for clinicians. However it is a rather 
time-consuming tool, taking around 3 hours to complete, and was designed to be 
more stringent than DSM-IV criteria to avoid false positives. 
ADI/-R 
The ADI-R studies scored best out of the informant-report instruments, and in 
between the two best and two worst scoring instruments overall, according to the 
critical appraisal tool. There were some methodological concerns with the available 
research and therefore it would be important to conduct further, more rigorous 
investigation of the ADI-R for use with adults; however it seems fair to consider the 
existing research sufficiently sound in order to contemplate the tool further.  
The ADI-R demonstrated good sensitivity and specificity. Reliability data 
were however somewhat limited for the ADI-R. There was no information available 
on its test-retest reliability, and data on inter-rater reliability were available from one 
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study but only as a figure that clinicians had to reach to become reliable rather than a 
check of the reliability on ratings completed for the purpose of the study. Internal 
consistency was only reported for the ADI-R when used with adults with learning 
disabilities, and this fell below acceptable levels (0.58; Sappok et al., 2013). The 
ADI-R also requires training and practice in its administration and takes over an hour 
and half to complete. ADI-R kits cost £273 each, with each additional interview 
booklet costing over £16, and the DVD training package retails at over £1000 
(retrieved from www.pearsonclinical.co.uk). It is therefore a somewhat expensive 
and time-consuming tool to train in and use.  
In terms of clinical use of the ADI-R, this review concludes there is evidence, 
albeit somewhat limited, that the ADI-R is suitable for use when an informant is 
available in order to gather information about the individual’s developmental history. 
As it is not a stand-alone diagnostic tool, other instruments such as the ADOS 
module 4 and RAADS-R would be helpful clinical adjunct tools for making a 
diagnosis when the ADI-R is used.  
The ADI-R is the one of the only tools validated for use with adults with 
learning disabilities, along with the ADOS. However it does still demonstrate some 
difficulties within this population, as it currently appears to have low internal 
consistency when used with adults with learning disabilities. This highlights the 
importance of using it as an adjunct tool alongside the ADOS when assessing adults 
with learning disabilities. 
ASDI 
Good test-retest reliability, inter-rater reliability, and sensitivity and 
specificity were demonstrated for the ASDI; but there was no report on the internal 
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consistency of the tool. However, like the AAA, the ASDI study scored particularly 
low according to the critical appraisal tool. The level of methodological concern 
about the study, including a limited sample size and lack of description of 
participants, is again significant and would suggest that any evidence for its value 
should be considered preliminary. Although recommended for use by NICE (2012), 
this review suggests that further more rigorous research of the ASDI is needed before 
it can confidently be recommended for use. Furthermore, the ASDI is developed to 
make diagnoses according to Gillberg & Gillberg (1989) criteria rather than DSM-
IV/DSMI-5 or ICD-10 criteria, again limiting the usefulness of this tool for 
diagnostic services in the UK. The ASDI is however freely available and does not 
require training, meaning it is an easily accessible tool for clinicians to use. 
DISCO 
Like the ADI-R, the DISCO studies fell in between the two best and two 
worst scoring instruments overall according to the critical appraisal tool, but rated 
second best out of the four informant report tools. There were methodological 
concerns, namely a very small sample of participants without ASD (n=6), and a lack 
of important psychometric data included in the DISCO research. Although the tool 
scores sufficiently well to warrant considering it further, it is important that further, 
more rigorous investigation of the DISCO when used with adults is conducted. 
The DISCO was the only measure considered in this review in which 
specificity was notably low at only 50 percent, meaning there is a high risk of over 
diagnosis. However, as highlighted earlier, this may be a very imprecise measure of 
the specificity due to methodological flaws in that not enough non-ASD participants 
were included in the study. Data on the inter-rater reliability of the DISCO were 
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mixed; no information is given for the overall scale, however most (>90%) 
individual items scored within an acceptable range.  No data were available on 
internal consistency or test-retest reliability. It is acknowledged that NICE (2012) 
recommend the DISCO to ‘organise and structure a diagnostic assessment’ rather 
than as a diagnostic tool due to the lack of investigation of its diagnostic utility in an 
adult population. Although this review uncovered a study of the DISCO with adults, 
it confirms that DISCO cannot be recommended for diagnostic use at this time, on 
the basis that important reliability information is unknown and currently 
unacceptable levels of specificity have been demonstrated when used with adults.  
Self-report tools 
Self-report tools overcome the difficulties described above with informant 
based interviews as they require only the person in question to answer questions. 
However it should be considered that there can be problems with self-report, as it has 
been suggested that individuals with ASD have poor self-referential cognition 
(Lombardo, Barnes, Wheelwright, & Baron-Cohen, 2007) and limited insight 
(Bishop & Seltzer, 2012) which may make self-report more difficult. Indeed 
informant score yielded higher sensitivity and specificity than self-report on the 
Broad Autism Phenotype Questionnaire (BAPQ; Hurley, Losh, Parlier, Reznick & 
Piven, 2007) and it has been found that people with ASD underscore their symptoms 
when using the AQ (a self-report ASD screening tool; Bishop & Seltzer, 2012). The 
only fully self-report tool considered here is the RAADS-R. 
RAADS/-R 
The RAADS-R studies were the most methodologically sound according to 
the critical appraisal tool. It can therefore be considered to have good quality 
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evidence for its use. From the three papers on the RAADS-R there is clear evidence 
of good internal consistency and test-retest reliability, and good sensitivity and 
specificity. A measure of inter-rater reliability of this instrument is not applicable due 
to it being a self-rating measure. The RAADS-R is a freely available tool, which 
would require little training due to its self-report nature. It is also relatively quick 
(around 30 minutes) to administer. This makes the RAADS-R a good option for 
clinicians with limited resources. 
This review suggests that the RAADS-R would be a suitable option for 
making a diagnosis in an adult for whom there was no informant available. As it is 
not a stand-alone instrument, it would be helpful in this case to combine the 
RAADS-R with a tool such as the ADOS. The RAADS-R could also be used 
alongside an informant-based interview such as the ADI-R, as a means of 
triangulating information from various sources. 
There is also evidence that the RAADS-R can distinguish between those with 
ASD and those with other DSM-IV-TVR axis 1 diagnoses, as Ritvo et al. (2011) 
included a large clinical comparison group in their study. Although this area needs 
more investigation, this implies that RAADS-R may also be a useful tool for cases in 
which someone has or is suspected of having another clinical diagnosis. 
Observational tools 
Observational tools overcome the difficulties described above experienced by 
informant and self-report. However these tools involve one-off observations and 
therefore cannot provide information on everyday functioning and developmental 
history. The only observation tool considered here was the ADOS. 
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ADOS 
The ADOS studies scored highly on the critical appraisal tool, suggesting that 
overall the studies are methodologically sound and the ADOS can be considered to 
have good quality evidence for its use. It showed acceptable to good internal 
consistency and inter-rater reliability, however no study has yet reported on the test-
retest reliability of this tool when used with adults. Sensitivity and specificity were 
good, although specificity was slightly lower in the ADOS specifically when used 
with adults with learning disabilities (0.65; Sappok et al., 2013).  
It should be noted that the ADOS is an expensive tool to use which requires a 
significant amount of training. The cost of the ADOS-2 kit is cited as £2078, with 
each additional scoring booklet costing just under £6, and the DVD training packages 
retailing at over £1000 each (retrieved from www.pearsonclinical.co.uk).  The 
ADOS also requires ongoing reliability monitoring, making this a demanding tool in 
terms of time and effort required from clinicians. Despite its cost, current evidence 
suggests that the ADOS module 4 would be useful clinical adjunct tool for making a 
diagnosis in an adult, both when an informant is available and when one is not.  
Although some other instruments included mixed clinical comparison groups, 
e.g. any axis 1 DSM-IV-TR diagnosis (Ritvo et al. 2008, 2011),  the ADOS module 4 
was the only instrument be investigated when used with comparison groups with 
other specified clinical diagnoses, namely groups with psychopathy and 
schizophrenia. The ADOS module 4 can be used to distinguish between males with 
ASD and psychopathy, using the revised algorithms suggested by Bastiaansen et al. 
(2011), making it a particularly useful clinical adjunct tool for adult males with 
psychopathy. To some degree it can also help distinguish between adult males with 
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ASD and schizophrenia, although this distinction is more difficult to make and is 
better based on individual ADOS module 4 items rather than overall score 
(Bastiaansen et al., 2011).  
The ADOS is one of the only tools, along with the ADI-R, with evidence 
supporting its use in a population of adults with learning disabilities. Although it is 
noted above that the ADOS demonstrates lower specificity in learning disability 
populations, this is only when using ASD cut offs (as used in the current review for 
standardisation purposes). Higher specificity was found for the ADOS in this 
population when autism cut offs were used (specificity = 0.8; Sappok et al., 2013). 
The ADOS should therefore be the tool of choice, along with the ADI-R, when 
assessing a person with learning disabilities, as these are the only tools in which clear 
attempts have been made to validate them for use with adults with learning 
disabilities.  
Suggestions for future research 
There is clearly the need for further research into tools for the diagnosis of 
adults with ASD. Of the six tools recommended by NICE, half had had only one 
paper published in relation to their use with adults, and all of these had significant 
limitations as discussed above. The other tools had a least three papers each covering 
their use with adults, but all would still benefit from further investigation to fully 
understand their strengths and weaknesses with different populations of adults with 
suspected ASD.  
It is notable that the evidence for the existing informant report tools is weak 
or mixed. This review has concluded that at present the AAA and ASDI do not 
currently have adequate quality research to recommend their use, and the DISCO 
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does not demonstrate satisfactory psychometric properties in order to recommend its 
use with adults. Although there was some evidence for use of the ADI-R this was 
mixed. There is clearly a need for further research into these tools, or for the 
development of new informant based tools. As the AAA, DISCO and ADI-R are 
particularly time consuming interviews, and the DISCO and ADI-R require extensive 
training, the development of a new informant based interview which was shorter and 
demanded less training would be ideal. 
Based on the critical appraisal tool used for this literature review, which was 
highly relevant to the validation of tools to diagnose ASD, future research on new or 
existing tools would benefit from the inclusion of as many as possible of the 
suggestions below. It should be noted that there are many practical challenges to 
carrying out such research, for example it can be difficult to recruit large samples 
where research budgets are small and to collect psychometrics such as test-retest 
reliability where time is limited. It is therefore recognised that it may not be possible 
to carry out research which fulfils all the suggestions; however it would be best 
practice to adhere to as many as practically possible.  
An ideal study would be one in which a gold reference standard were used for 
diagnosis of ASD, namely clinician consensus diagnosis made according to DSM-5 
or ICD-10 criteria. The sample of participants would be well described (including 
age range, mean and standard deviation as well as gender ratio of participants), 
recruited from different locations or clinics, and formed of separate groups of at least 
20 participants both with and without ASD (or ideally more). An identifiable group 
of participants with other clinical conditions that may have features that could be 
confused with ASD, such as symptoms of psychosis or social anxiety, would be 
important – as it is likely to be easier to distinguish between ASD and people with no 
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clinical symptoms compared to distinguishing between ASD and those with 
symptoms that might overlap with ASD. It is also helpful for participants to have 
completed a measure of cognitive ability in order to understand the cognitive profile 
of the group with which the measure is validated, as well as ensuring similar 
cognitive abilities between comparison groups. Assessors would be blind and the 
reference standard diagnosis would be made without the influence of the test under 
investigation (i.e. the index tool would not be used when making the diagnosis to 
which this tool was compared). The paper would provide a detailed description of the 
method and how data was analysed, including procedures for scoring and dealing 
with missing data. Ideally the paper would report sensitivity and specificity figures, 
giving the raw numbers from which this was derived, as well as other psychometric 
data looking at different types of reliability and validity. 
Conclusions 
This review examined the body of literature available on the psychometric 
properties of the NICE recommended tools for the diagnosis of ASD in adults. The 
review provides support for the use of the RAADS-R and the ADOS with adults, and 
some support for the use of the ADI-R. The best tools for use in different 
circumstances are discussed. The review considered the evidence for the AAA, ASDI 
and DISCO too weak at present to provide good evidence for their use in diagnosing 
adults. This does not mean however that they will not present themselves to be 
highly useful tools for use with adults in the future, but further research is necessary. 
Indeed for all the tools, further research is indicated, especially to validate the tools 
for use within specific populations of adults with other clinical diagnoses. The 
development of new informant report tools for adults may also be beneficial. 
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Validating the Developmental, Diagnostic and Dimensional Interview - Short 
Form Adult Version (3Di-sva): a diagnostic interview for autism spectrum 
disorders in adults 
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Abstract 
Aims. There is a lack of validated diagnostic tools for adults with autism spectrum 
disorders (ASD). This study aims to evaluate the reliability and validity of a new, 71-
question informant-report tool, the Dimensional, Developmental and Diagnostic 
Interview – short version for adults (3Di-sva). The 3Di-sva generates scores for 
subscales reflecting the DSM-5 ASD diagnostic criteria.  
Methods. The 3Di-sva was administered to a parent (or an alternative informant) of 27 
adults with ASD and 27 non-clinical comparison adults. A subset (ASD n=17, 
comparison n=24) of participants completed an estimate of IQ, and where possible 
interviews were audio-recorded and independently coded to evaluate inter-rater 
reliability (ASD n=10, comparison n=15). Participants with ASD also completed the 
Autism Diagnostic Observation Schedule (ADOS). 
Results. The 3Di-sva demonstrated good reliability as measured by internal consistency 
and inter-rater reliability. Criterion validity was strong: ASD participants scored 
significantly higher than comparison participants on all subscales, and sensitivity (93%) 
and specificity (100%) were high. In the ASD group, there was however low correlation 
between 3Di-sva scores and ADOS scores. Construct validity was partially 
demonstrated: as expected there was strong correlation between scores on the two main 
scales of the 3Di-sva. However scores on the 3Di-sva subscales were not significantly 
associated with IQ score or gender, but were associated with age for the A-scale (Social 
Interaction and Communication) in the comparison group.  
Conclusions. The 3Di-sva demonstrates good psychometric properties and is a time and 
cost-efficient tool that could be suitable for use a part of a multi-dimensional ASD 
assessment. Future research should examine the test re-rest reliability of the 3Di-sva and 
its reliability and validity when used with a clinical control population. 
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Introduction 
Autism spectrum disorders 
Autism spectrum disorders (ASD) are conceptualised by The Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric 
Association [APA], 2013) as conditions in which deficits are seen in two functional 
domains, often referred to as a dyad of impairments. The two domains are social 
communication and interaction and restricted and repetitive behaviours. For a 
diagnosis to be made, symptoms must begin in early childhood, although they may 
not be recognised until later in life, and must cause functional impairment. The 
concept of a dyad of impairments is a change from the previously accepted notion of 
a triad of impairments, in which symptoms were clustered into three domains: 
language and communication, reciprocal social interaction, and restricted, repetitive 
and stereotyped behaviours and interests (DSM-IV-TR; APA, 2000). The DSM-5 
diagnostic entity of an autism spectrum disorder subsumes the DSM-IV-TR separate 
categories of diagnosis such as autism, Aspergers, and atypical autism. 
The prevalence of ASD among UK children is around 1.5%, with the ratio of 
known to unknown cases estimated to be 3:2 respectively (Baron-Cohen et al., 2009). 
As many cases go undetected in childhood, and a recent review of outcome studies 
has shown that children with ASD do not grow out of the condition (Howlin & Moss, 
2012), a number of individuals with ASD are likely to progress to adulthood without 
receiving a diagnosis. In particular, individuals with mild or late-appearing 
symptoms may be less likely to come to clinical attention until they reach 
adolescence or adulthood (Ritvo, Ritvo, Freeman & Mason-Brothers, 1994). The 
occurrence of ASD within community adult populations in England is similar to that 
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reported for children, and there is no significant decrease in prevalence of ASD 
across adult age groups (Brugha et al., 2011).  
It is well known that there is a higher rate of ASD amongst males, with male 
to female ratios found to be between 3:1 and 4:1 (e.g. Baird et al., 2006, Chakrabarti 
& Fombonne, 2001). Within the typically developing general population, males have 
demonstrated significantly higher levels of ASD traits than females in both child 
(Constantino & Todd, 2003) and adult populations (Baron-Cohen, Wheelwright, 
Skinner, Martin & Clubley, 2001). Evidence also shows that females are less likely 
than males to receive a diagnosis of ASD at equivalent levels of autistic traits 
(Dworzynski, Ronald, Bolton & Happé, 2012). This may be because females have 
developed better compensation or adaptation strategies, or due to gender stereotypes 
in the diagnostic process (Dworzynski et al., 2012).  Therefore, although within the 
general population males may demonstrate higher ASD traits than females, within a 
clinical population this is less likely, as females will often need to display more 
severe traits of ASD in order to receive a diagnosis.  
According to a US-based community survey of children with ASD, 31% had 
an IQ in the intellectual disability range (IQ below 70) and 69% did not (IQ above 
70) (Centres for Disease Control and Prevention, 2014), which suggests that majority 
of people with ASD do not have an intellectual disability. There has however been 
found to be a relationship between verbal IQ score and prevalence of ASD within the 
normal range of intelligence (i.e. over 70), with higher levels of ASD found in adults 
who score lower on a verbal IQ test (Brugha et al., 2009).  
After the publication of the Autism Act 2009, the government set out the 
Strategy for Adults with Autism in England (Department of Health, 2010). Key 
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actions stated within the strategy included the development of local autism teams, 
planning and commissioning of autism services, and improving access to diagnosis 
and post-diagnostic support. The importance of diagnosis for adults who have 
previously not had their condition recognised is highlighted, and it is stated that 
capacity for adult diagnosis of ASD must be increased. Recent National Institute of 
Clinical Excellence guidelines on autism in adults (NICE, 2012) also note that there 
is wide variation in diagnostic practice for adults with features of autism, which lead 
to delays in diagnosis and access to appropriate services. The guidelines also 
highlight the importance of a clear and consistent care pathway to diagnosis for 
adults with ASD. 
Diagnostic tools for adults 
It is therefore important that good quality tools to assess and diagnose ASD in 
adulthood are available. However, many of the instruments currently used for the 
assessment of ASD are focused on toddlers and children and there is a lack of well 
validated diagnostic instruments suitable for use with adults. There are currently 
three types of standardised tools used for adults: direct observation, self-report, and 
informant report. 
The Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2000) is 
the only NICE (2012) recommended observational tool. It is suitable for use with 
both children and adults, with the ADOS module 4 being designed specifically for 
use with adolescents and adults with fluent speech (Lord et al., 2000). It is a well 
validated instrument with good psychometric properties, for example good inter-rater 
reliability (Bastiaansen et al., 2011) and sensitivity and specificity exceeding 80% for 
Module 4 (Hus & Lord, 2014). The ADOS therefore has value when assessing ASD 
 
 
59 
 
in adults, although there are some drawbacks in that extensive training is required to 
administer it and it is expensive to procure and use (Charman & Gotham, 2013).  
The Ritvo Autism and Asperger Diagnostic Scale: Revised (RAADS-R; 
Ritvo et al., 2011) is the only NICE (2012) recommended self-report tool. It has 
demonstrated good psychometric properties, for example very high test-retest 
reliability, good internal consistency, and sensitivity and specificity of over 90%, 
(Ritvo et al., 2011; Anderson et al., 2011). This tool is therefore also valuable for 
assessing ASD in adults, however it should be noted that some individuals with ASD 
have poor self-referential cognition (Lombardo, Barnes, Wheelwright & Baron-
Cohen, 2007) and limited insight (Bishop & Seltzer, 2012) which may make self-
report difficult in such cases. Indeed it has been found that informant score yielded 
higher sensitivity and specificity than self-report on the Broad Autism Phenotype 
Questionnaire (BAPQ; Hurley, Losh, Parlier, Reznick & Piven, 2007) and that 
people with ASD underscore their symptoms when using a self-report screening tool, 
the Autism-Spectrum Quotient (AQ; Bishop & Seltzer, 2012).  
Informant report instruments also provide valuable information for an adult 
ASD assessment. The NICE (2012) recommended informant report tools are the 
Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter & Le Couteur, 1994), 
the Diagnostic Interview for Social and Communication Disorders (DISCO; Wing, 
Leekham, Libby, Gould, & Larcombe, 2002), the Adult Asperger Assessment (AAA; 
Baron-Cohen, Wheelwright, Robinson, & Woodbury-Smith, 2005), and the Asperger 
Syndrome Diagnostic Interview (ASDI; Gillberg, Gillberg, Rastam & Wentz, 2001).  
The AAA and the ASDI were designed specifically for adults, with the AAA 
being a semi-structured and the ASDI being a more highly structured interview. 
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There is currently however only limited evidence available for both of these, as only 
one paper published by the developer of the instrument is available for each (Baron-
Cohen et al., 2005, Gillberg et al.2001) and the sample sizes are notably limited in 
both cases. There currently exists no published reliability data, such as inter-rater 
reliability, internal consistency or test-retest reliability, for the AAA, which is also a 
time consuming instrument to administer, taking around 3 hours to complete (Baron-
Cohen et al., 2005). Additionally, the AAA was designed to be more stringent than 
DSM-IV criteria to avoid false positives and the ASDI is developed to make 
diagnoses according to Gillberg & Gillberg (1989) criteria rather than DSM-IV-TR, 
DSM-5 or ICD-10 (World Health Organisation, 1992) criteria, therefore limiting 
their usefulness for diagnostic services in the UK. 
The ADI-R and the DISCO are semi-structured interviews initially designed 
for use with the parents of children but also recommended as suitable for the 
assessment of adults (NICE, 2012). However, the only published paper examining 
the use of the DISCO with an adult population includes a sample of only six non-
ASD participants and demonstrates poor specificity (Nygren et al., 2009), meaning 
that currently there is limited evidence for its value when used with adults. The 
DISCO is also a time consuming instrument to complete, taking between two and 
four hours (Charman & Gotham, 2013). The ADI-R presents as a more promising 
tool, for example it has been shown to demonstrate high sensitivity and specificity 
(Lord et al., 1997). However, there is still a lack of good quality data published 
regarding the reliability of the instrument when used with adults. Additionally, there 
are drawbacks to the ADI-R; it takes around two hours to complete (Constantino et 
al., 2003), requires extensive training in its administration, and is costly to procure 
and use (Charman & Gotham, 2013).  
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Therefore, although promising observational and self-report tools exist, the 
NICE (2012) recommended informant-report tools demonstrate several problems. 
There is a lack of sufficient psychometric data available on the instruments, several 
of the tools are costly to train in and use, and, with the exception of the ASDI, they 
take several hours to complete. An informant-report instrument is needed which 
demonstrates good psychometric properties, is easy to train in and non-expensive to 
use, which is also short enough to be a realistic and useful part of an assessment in 
health services which are often stretched in terms of time due to financial restraints. 
Further development and research of informant-report tools is therefore 
worthwhile, in order to improve our diagnostic capacity for adults with ASD. There 
are several reasons why it is important that good quality informant-report instruments 
are available. Although it is recognised that ASD symptoms may not become fully 
manifest until adolescence or adulthood, the DSM-5 criteria for a diagnosis of ASD 
state that symptoms must have been present during early childhood, meaning it is 
very important to explore an individual’s early symptoms with someone who knew 
them well as a child. Informant report can also be particularly helpful when 
considering alternative diagnoses. ASD is associated with extensive comorbidity 
(Mukaddes, Hergüner, & Tanidir, 2010), and it can present with similar features to 
other disorders (for example schizophrenia (Baastiansen et al., 2011), and some 
forms of anxiety (Zandt, Prior, & Kyrios, 2009)). Informant report regarding 
developmental history can assist a clinician to differentiate between such diagnoses 
and ASD.  Also, as discussed earlier, individuals with ASD can experience 
difficulties with self-report instruments meaning that availability of third party 
information is likely to be a useful adjunct in any assessment of adult ASD.  
 
 
 
62 
 
The 3Di-sv 
A new informant-report tool which could be useful for the diagnosis of ASD 
in adults is the Dimensional, Developmental and Diagnostic Interview (3Di; Skuse et 
al., 2004). The 3Di is a standardized parent interview designed to measure autistic 
features dimensionally, which can be administered to unselected clinical and general 
populations. The original version contained a diagnostic algorithm with 113 items, 
however a new shorter version was later developed (3Di-sv; Santosh et al., 2009) 
comprising a subset of just 53 items. The 3Di is well validated and reliable for use 
with child populations (Skuse et al., 2004, Santosh et al., 2009); however there is no 
evidence yet that it is suitable for use in an adult population.  
The measure was however recently adapted into a specific adult version 
(Developmental, Diagnostic and Dimensional Interview - Short Form Adult Version; 
3Di-sva). The adult version was developed by analysing which questions in the 3Di-
sv were best able to discriminate between those with and without ASD in older 
adolescent populations. Following this analysis some items were modified to make 
them more relevant to adults, and some new questions were added based upon 
knowledge of the ASD phenotype in adults and upon new DSM-5 criteria. The adult 
version includes 71 questions, which ask both about the individual’s development as 
a child and their functioning in the present day. It is intended for use with adults with 
intellectual ability within the normal range, reflecting the fact that the original 3Di 
was designed for higher-functioning individuals.   
Small-scale pilot research has suggested that the measure is able to 
discriminate effectively between adults with and without ASD, which indicates that 
the 3Di-sva is worth investigating further. The pilot research explored the validity of 
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3Di-sva subscales using a prototype of the instrument designed to measure the DSM-
IV-TR construct of the ‘triad of impairments’. As this has now been updated to a 
‘dyad of impairment’ in the DSM-5, the 3Di-sva has since been revised to generate 
subscale scores according to the criteria for these two dimensions as opposed to the 
three originally developed. 
It takes around one hour to train individuals how to score responses and 45 
minutes to conduct the 3Di-sva. Scoring can be done easily using a computer 
algorithm.  The interview is highly structured and consequently suitable for 
administration both in person and by telephone. The 3Di-sva is therefore potentially 
a time-efficient and practical informant-report instrument compared to the ADI-R, 
DISCO and AAA. Further benefits of the tool are that it is designed to make both 
dimensional and categorical assessments, giving an overall diagnosis as well as 
scores on subscales linked to the DSM-5 criteria, and it allows for the identification 
of specific areas of ability or impairment in both clinical and non-clinical 
populations. The 3Di-sva is therefore potentially a useful diagnostic tool for adult 
ASD which could form part of a standardised assessment. 
Research aims 
In order to evaluate the 3Di-sva for potential use within adult ASD diagnostic 
services, we need to investigate the reliability, criterion validity and construct 
validity of the instrument.  To assess criterion validity, it is essential to investigate 
the 3Di-sva’s ability to discriminate between ASD and non-ASD populations. This 
report focuses on its ability to discriminate ASD and a non-clinical comparison 
population, however the research was completed as part of a joint project in which 
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ability to discriminate ASD and a clinical comparison population was also examined 
and is reported elsewhere (McKenner, 2015).  
To further investigate criterion validity it will be useful to explore the 3Di-
sva’s relationship to another adult ASD diagnostic tool, the ADOS module 4. To 
assess construct validity, correlation between the subscales of the 3Di-sva will be 
examined, as well as correlation between score and IQ (as there is usually a 
correlation between ASD traits and IQ) and score and gender in the comparison 
population (as traits of ASD are generally higher within males in the typically 
developing but not the clinical population). It would also be interesting to check for 
any correlation between age and 3Di-sva score; none would be expected as there is 
no known relationship between age and ASD traits. 
The current study therefore addresses the following questions:  
1) Does the 3Di-sva demonstrate good reliability, in terms of having high: 
a.  inter-rater concordance, and  
b. internal consistency? 
2) Does the 3Di-sva have criterion validity, as demonstrated by: 
a. effective discrimination between ASD and a non-clinical comparison 
population, and 
b. a significant correlation between 3Di-sva scores and scores on the 
ADOS module 4, in people diagnosed with ASD? 
3) Does the 3Di-sva have construct validity, as demonstrated by: 
a. a significant correlation between scores on the social communication 
and interaction scale and the restricted and repetitive behaviours scale, 
b. a significant correlation between 3Di-sva score and estimated IQ,  
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c. significantly higher 3Di-sva scores in males in the comparison 
population, and 
d. no significant correlation between 3Di-sva score and age? 
Method 
Design 
This study used a cross sectional, between-subjects design to assess the 
psychometric properties of the 3Di-sva when used with people with and without 
ASD, using quantitative methods. The study was conducted as part of a joint research 
project with another UCL DClinPsy trainee, Michele McKenner (McKenner, 2015). 
See Appendix 3 for breakdown of individual contributions to project. 
Participants 
Inclusion and exclusion criteria 
Participants in both the ASD and comparison groups were required to be aged 
18 or over for inclusion. Exclusion criteria for both groups included 1) participant 
learning disability (as indicated by an estimated IQ under 70), as the interview is 
designed to assess people with an IQ within the normal range, and 2) no informant 
available to complete the 3Di-sva. 
Additional inclusion criteria for the ASD group included, 1) meet threshold 
for a diagnosis of ASD on the ADOS module 4 (i.e. score at least 7 or above on the 
combined communication and social interaction scale), and 2) ASD diagnosis 
confirmed by clinician consensus opinion (based upon DSM-IV-TR criteria for 
autistic or Asperger’s disorder or DSM-5 criteria for autism spectrum disorder). It 
was considered essential that all participants first met the threshold for ASD on the 
ADOS in order to avoid circularity, as although the 3Di-sva algorithm was not used 
when making diagnoses, information gathered from informants during the 3Di-sva 
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did contribute to the diagnostic decisions made by clinicians. Clinician consensus 
opinion was then used to control against the inclusion of false positive cases from the 
ADOS module 4. 
Additional exclusion criteria for the comparison group were: 1) current 
mental health difficulties (a separate group with mental health difficulties were 
recruited and are reported on by McKenner (2015)), 2) any current or previous 
concerns around having an ASD, and 3) participant or informant unable to speak 
fluent English (due to lack of resources to provide an interpreter). 
Sample 
The overall sample collected as part of the joint work with McKenner (2015) 
included 74 participants aged 18 – 59. Three separate groups were recruited, 27 
participants with ASD, 27 typically developing comparison participants, and 20 
comparison participants with mental health difficulties. McKenner (2015) conducted 
analyses examining the use of the 3Di-sva when used with adults with mental health 
difficulties. The current analysis looks at the 3Di-sva when used with adults with 
ASD (ASD group) and non-clinical control adults (comparison group). The 
demographics of the sample are displayed in Table 1.  
The number of participants recruited for the study was not based upon a power 
analysis as we were not concerned with the 3Di-sva’s capacity to detect small, subtle 
between-group differences. The number of participants recruited was instead 
determined by the maximum number it was feasible to recruit within given time and 
financial restrictions. Post hoc power analyses show that sufficient power (0.80) was 
achieved to detect a large effect size in all of the t-test, Mann Whitney U, and 
correlational analyses. 
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Table 1 
Participant demographics. 
Group N % Male Mean age (SD), 
min-max 
Mean est. IQ (SD), 
mix-max 
ASD 27 67 35.63 (13.32),  
18 – 59  
109.47 (16.89),  
72 – 138  
Comparison 27 56 29.54 (8.87),  
18 – 52  
115.7 (10.30),  
89 – 133  
Overall sample 54 61 32.64 (11.66),  
18 – 59 
113.12 (13.59),  
72 – 138  
Note. Age is unknown in one comparison group case. Mean estimated IQ is based on scores for 17 
ASD group cases and 24 comparison group cases. IQ scores were based on estimates provided by the 
TOPF in all cases except two ASD group cases which completed the WASI and six ASD group cases 
who completed the WAIS-IV. Where scores were not obtained, IQ was assumed to be in the normal 
range. 
 
The ASD group were recruited from two adult ASD diagnostic clinics in 
London. The standard diagnostic process within both clinics included the completion 
a clinical interview, ADOS module 4, and 3Di-sva interview (where an informant 
was available). Diagnosis was based upon the consensus decision of the team, 
consisting of clinical psychologists and consultant psychiatrists. Of the ASD group, 
15 cases had completed their assessment within the past two years and consented for 
their anonymised data to be included in research. Each of these cases were contacted 
by the researchers and asked to complete the Test of Premorbid Functioning (TOPF; 
Wechsler, 2009) for the purposes of the current research. A further 12 cases were 
recruited at the time that they attended the clinic for their assessment. See Figure 1 
for a flowchart of recruitment to the ASD group. 
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Figure 1. ASD group recruitment flowchart. 
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The comparison group were recruited using convenience sampling methods, 
from adverts placed around a university campus and sent to friends and colleagues of 
the researchers. Potential participants were asked to contact the researchers to 
express their interest in taking part. 
Ethics 
All aspects of the study were approved by the Bloomsbury NRES Committee 
and by relevant local Research & Development departments. All participants 
recruited provided informed consent before taking part in the research, and historical 
ASD group cases provided consent at the time of their assessment for their 
anonymised data to be included in research. All research data was collected and 
stored according to the Data Protection Act 1998. See Appendix 4 for letter giving 
ethical approval, Appendix 5 for information sheets, Appendix 6 for consent forms, 
and Appendix 7 for invitation letter sent to the historical ASD cases. 
Measures 
Developmental, Diagnostic and Dimensional Interview - Short Form Adult Version 
(3Di-sva)  
The 3Di-sva is an informant report, semi-structured interview designed to 
assess and diagnose autism spectrum disorders in adults.  It was adapted from the 
short form 3Di (Santosh et al., 2009) used in child and adolescent populations.  It 
provides an assessment of the areas of autistic impairment highlighted by the DSM-
5. The interview asks questions about both developmental history and current 
behaviour. It is carried out with an informant who knew the person both as a child 
and currently. In most cases this is a parent, but it could also be other family 
members or friends.  
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The 3Di-sva consists of 71 interview questions, 67 of which are included in 
the scoring algorithm. The remaining four questions measure developmental 
milestones. Questions included in the algorithm are arranged into two main scales, 
the ‘A-scale’ which reflects the DSM-5 Social Interaction and Communication 
dimension, and the ‘B-scale’ which reflects the DSM-5 Restricted, Repetitive 
Patterns of Behaviour, Activities or Interests dimension. The A-scale and B-scale are 
comprised of separate subscales reflecting the DSM-5 diagnostic criteria, forming a 
total of seven subscales. The arrangement of questions within the subscales is 
displayed in Figure 2. 
 
 
 
 
 
 
 
 
 
 
Figure 2. 3Di-sva scoring algorithm arrangement. 
A-scale: Social communication 
and interaction 
 
B-scale: Restricted, repetitive 
patterns of behaviour, 
interests or activities 
 
A1: Social emotional reciprocity 
14 questions 
 
A2: Deficits in nonverbal behaviour used 
for social interaction 
17 questions 
 
A3: Deficits in forming, maintaining and 
understanding relationships 
18 questions 
 
B1: Stereotyped or repetitive movements  
3 questions 
B3: Restricted fixated interests 
5 questions 
 
B4: Abnormal sensory response 
5 questions 
 
B2: Insistence on sameness 
5 questions 
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Questions are scored on either a three point (either 0= Often, 1= Sometimes, 
2= Never, or vice versa) or four point Likert scale (0= No, 1= Yes, minimal, 2= Yes, 
persistent, 3= Yes, persistent with functional impairment). The only exception is the 
four questions about developmental milestones, in which two scoring options are 
available (0= within the normal range, 1= outside of the normal range). All questions 
receiving a score of 3 are recoded to 2 when calculating algorithm scores in order to 
ensure that all items within a scale carry equivalent weight. Scores for each of the 
seven subscales are generated by totalling the responses to each of the relevant 
questions and an overall score for the A-scale (Social Communication) and the B-
scale (Restricted repetitive behaviour, interests or activities) are generated. As there 
are many more items making up the subscales of the A-scale than the B-scale, all 
scores are scaled in order to give each subscale an equal weighting.  
Test of Premorbid Functioning – UK Version (TOPF; Wechsler, 2009) 
The TOPF is a brief measure used to predict full scale IQ for individuals aged 
16 to 89 years. The test involves reading out a list of up to 70 words that have 
atypical grapheme to phoneme translations. Individuals are asked to read the words 
out loud in order and stopped if they pronounce more than 5 words incorrectly in a 
row. It takes around five minutes to complete. Full scale IQ score is predicted based 
on number of words correctly pronounced, number of years of education and age. 
The TOPF has been shown to demonstrate good internal reliability (0.95), good test-
retest reliability (0.89-0.95), and high correlation (0.81) with full scale IQ score as 
predicted by the Wechsler Adult Intelligence Scale- fourth edition (WAIS-IV; 
Wechsler, 2008). It has been validated for use in various populations including 
individuals with ASD. 
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Autism Diagnostic Observation Schedule (ADOS-G) Module 4 (Lord et al., 2000) 
and ADOS Diagnostic Observation Schedule 2 (ADOS-2) Module 4 (Lord et al., 
2012) 
The ADOS is a standardized semi-structured observational assessment 
consisting of tasks and questions which an examiner carries out with the individual 
with suspected ASD.  It assesses communication, reciprocal social interaction, 
imagination/creativity, and stereotyped behaviours and restricted interests. Module 4 
of the ADOS is used for adolescents and adults with fluent speech. It places a greater 
emphasis on conversation, as opposed to play as in the other ADOS modules, to 
gather information about social-communication. An ADOS module 4 usually takes 
between 45 minutes to one hour to complete. The ADOS-2 is the recently updated 
version of the original ADOS-G, however for Module 4 both versions are very 
similar and there are no differences in the scoring algorithm used. The ADOS-G was 
used in 11 cases and the ADOS-2 in 17 cases in the current study.   
For Module 4 of both the ADOS-G and ADOS-2, various observed 
behaviours are coded using a three or four point Likert scale, which ranges from 0 
indicating no abnormalities, to 2 or 3 indicating definite difference or abnormality. A 
scoring algorithm is given in which a Communication and a Social Interaction score 
are generated. These are then combined to give a total score, which must reach a cut-
off score of 7 or above to indicate a diagnosis of ASD. Imagination/Creativity and 
Stereotyped Behaviours and Restricted Interests scores are also generated but not 
included in the diagnostic algorithm. The ADOS is often used as part of a gold-
standard ASD assessment and has demonstrated good psychometric qualities (e.g. 
Lord et al., 2000, Bastiaansen et al., 2011, Hus & Lord, 2014).  
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Procedure 
Participants were recruited between August 2014 and May 2015. The 3Di-sva 
interview was carried out with an informant for all participants in both groups. For 
the comparison group, the informant was the mother in the majority of cases (n=25), 
however a father (n=1) and older sister (n=1) also acted as an informant. For the 
newly recruited participants in the ASD group, the informants were mothers in all 
cases. Data is unavailable on who the informant was for the historical cases included 
in the ASD group, however clinician opinion was that the vast majority of historical 
interviews were also done with mothers. For the comparison group, interviews were 
carried out by the researchers over the telephone (n=24) or in person (n=4). For the 
newly recruited ASD group cases, the interviews were either carried out in person at 
the clinic (n=7) or over the telephone (n=5), by either the study researchers (n=10) or 
clinicians at the ASD clinics (n=2). All interviews for historical cases included in the 
ASD group were conducted by clinic clinicians. The method by which the 
information was collected for the historical cases is unknown, however clinician 
impression was that the majority included were conducted in person.  
All researchers and clinicians conducting 3Di-svas included in the study had 
been trained in its use. Interviews were audio recorded where possible. Recordings 
were gathered for 10 ASD participants and 15 comparison participants. Audio 
recordings were listened to and scored by one psychology undergraduate trained in 
using the 3Di-sva who was blind to participant group.  
Participants in both groups were asked to complete a TOPF as an estimate of 
IQ where possible (n=9 ASD group, n=24 comparison group). ASD group cases 
were not asked to complete a TOPF when a more comprehensive IQ test had been 
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completed as part of their clinic assessment; in these cases the IQ estimate generated 
from the alternative test was used.  This applied to eight ASD group cases (n= 2 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999), n=6 WAIS-
IV). All ASD group participants also completed an ADOS module 4 with a clinician 
at the ASD clinic. 
For the comparison group, participants and the informants who completed the 
3Di-sva interview were given a £10 voucher to thank them for their time. No 
payment was given to the ASD group as data was collected as part of the routine 
clinic assessment and it was deemed unethical to pay participants from this group 
when other individuals attending the clinic would not be paid if they were not 
suitable for inclusion in the research. 
Analysis 
Data analyses were conducted in SPSS, version 22. Missing data was dealt 
with by prorating subscale scores using the mean item score if less than 50% of the 
data was missing.  
Preliminary analyses were conducted to assess normal distribution of the 
variables and differences between groups on IQ and age were analysed. Inter-rater 
reliability of the 3Di-sva interviews was assessed using intra-class correlation 
coefficients. Cronbach’s alpha was used to test for internal consistency of the 
subscales. Independent samples t-tests or Mann Whitney U tests (depending on 
distribution of variables) were used to look for statistically significant differences 
between the two groups (ASD vs comparison) on scores for the 3Di-sva A-scale 
(Social communication and interaction) and B-scale (Restricted repetitive patterns of 
behaviour, interests or activities). Gender differences in comparison group for the 
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two 3Di-sva scale scores were also examined using independent sample t-tests or 
Mann Whitney U tests as appropriate. A Receiver Operating Characteristics (ROC) 
curve was generated to examine ability of the overall 3Di-sva score to discriminate 
between the ASD and comparison group. This was used to set optimal thresholds for 
indicating an ASD diagnosis which maximised sensitivity and specificity of the 
measure. Pearson or Spearman correlations (depending on distribution of data) were 
examined between the 3Di-sva scale scores and the ADOS module 4 scores. Pearson 
or Spearman correlations were also examined between 3Di-sva scale scores and age 
and estimated IQ. 
Results 
Preliminary analyses 
Normal distribution 
The distribution of each of the subscales, age, and estimated IQ were 
examined visually and using the Kolmogorov-Smirnoff test. Results of the 
Kolmogorov-Smirnoff test are displayed in Table 2. Distribution of the data for the 
subscales was found to differ significantly from normal in all cases for the combined 
group, and all cases apart from the overall A-scale for the comparison group. In the 
ASD group the subscale data was normally distributed, with the exception of scale 
B2. The distribution of age differed significantly from normal in the combined and 
ASD groups, but not in the comparison group. Estimated IQ was normally 
distributed in all cases. All analyses involving variables that were not normally 
distributed were carried out using non-parametric statistics. 
 Distribution of ADOS subscale data for the ASD group were also examined 
and found to differ significantly from normal in all cases (ADOS Communication: 
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D(27)=.18, p=.03; ADOS Social Interaction: D(27)=.29, p<.001; ADOS 
Imagination/Creativity: D(25)=.32, p<.001; ADOS Stereotyped Behaviours and 
Restricted Interests: D(25)=.32, p<.001; ADOS Combined Communication and 
Social Interaction: D(27)=.22, p=.002.). Analyses using ADOS data were therefore 
conducted using non-parametric statistics. 
Table 2 
Kolmogorov-Smirnoff test for normal distribution of variables 
 Kolmogorov-Smirnoff test 
 Comparison group ASD group Combined group 
A-scale  D(27)=.14, p=.16 D(27)=.10, p=.20 D(54)=.24, p<.001*** 
A1 D(27)=.22, p=.002** D(27)=.10, p=.20 D(54)=.20, p<.001*** 
A2 D(27)=.28, p<.001*** D(27)=.15, p=.11 D(54)=.17, p<.001*** 
A3 D(27)=.18, p=.03* D(27)=.13, p=.20 D(54)=.20, p<.001*** 
B-scale D(27)=.17, p=.04* D(27)=.08, p=.20 D(54)=.25, p<.001*** 
B1 D(27)=.53, p<.001*** D(26)=.13, p=.20 D(53)=.30, p<.001*** 
B2 D(27)=.41, p<.001*** D(27)=.21, p=.003** D(54)=.25, p<.001*** 
B3 D(27)=.25, p<.001*** D(27)=.14, p=.19 D(54)=.21, p<.001*** 
B4 D(27)=.51, p<.001*** D(27)=.13, p=.20 D(54)=.30, p<.001*** 
Age D(26)=.14, p=.20 D(27)=.17, p=.04* D(53)=.15, p=.005** 
IQ D(24)=.08, p=.20 D(17)=.11, p=.20 D(41)=.11, p=.20 
* = distribution of variable differs significantly from normal at p<.05; ** = distribution of variable 
differs significantly from normal at p<.01, *** = distribution of variable differs significantly from 
normal at p<.001. 
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Between group differences 
Using a Mann Whitney U analysis, the difference in age between the ASD 
and comparison groups did not reach significance, U=269.00, z= -1.47, p=.14, r=-
.20. Using independent sample t-tests, the difference between groups on estimated IQ 
was also not significant, t(39)=-1.47, p=.15, d=.47, 95% CI [-14.82, 2.36].  
Missing data 
Examination of the percentages of missing data showed that no particular 
question had an excessive amount of missing data. The overall maximum amount of 
missing data for any one question was 13% (for one question: ED5 ‘Once [name] 
started talking did they have conversations just to be sociable?’). The majority of the 
missing data for this question was missing from the ASD group (86%). There were 
19 questions with no missing data at all. Subscales scores were successfully 
generated for all cases apart from one ASD group case for scale B1. This person was 
missing data for two out of the three questions on this scale and therefore it was not 
possible to compute an overall scale score.  
Reliability 
Internal consistency 
Cronbach’s alphas are displayed in Table 3. Internal consistency was good 
for all subscales. Although internal consistency for B1: ‘Repetitive motor movements 
or speech’ was slightly lower than the other subscales this still falls within the 
acceptable range. The overall internal consistency of the two scales was very high. 
 
 
 
78 
 
Table 3 
Subscale Cronbach’s alphas (α) 
A: Social Communication and Interaction 0.97 
A1: Social Emotional Reciprocity 0.87 
A2: Deficits in nonverbal behaviour used for 
social interaction 
0.93 
A3: Deficits in forming, maintaining and 
understanding relationships 
0.95 
B: Restricted repetitive patterns of behaviour, 
interests or activities 
0.92 
B1: Stereotyped or repetitive movements 0.71 
B2: Insistence on sameness 0.87 
B3: Restricted fixated interests 0.79 
B4: Abnormal sensory response 0.82 
 
Cronbach’s alpha were examined for all scale items and for no scale was the 
Cronbach’s alpha significantly improved by the deletion of any items. Item-total 
correlations were also examined, with a correlation of less than .4 being considered 
particularly low. When examining all the items within the overall A-scale, some 
items were found to have low item-total correlations. These were L29 ‘Do 
conversations with [name] tend to go off in unexpected directions?’ (r=.30), NVC45 
‘Can [name] look disgusted?’ (r=.38), NVC47 ‘Do his/her expressions ever appear to 
be exaggerated or put on?’ (r=.29), and SE57 ‘How about sharing his/her excitement 
with others?’ (r=.23). Similarly some items within the overall B-scale had low item-
total correlations. These were I64 ‘Has [name] ever seemed unusually interested in, 
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and absorbed by, things that spin?’ (r=.38), I66 ‘Has [name] ever seemed unusually 
sensitive to sensations like touch or smell?’ (r=.36), and I68 ‘Has [name] ever shown 
any hand or finger mannerisms when excited or distressed?’ (r=.35). It was deemed 
unhelpful to remove any of these items as it did not improve the Cronbach’s alpha 
and removal would negatively affect the content validity of the interview by reducing 
its coverage of the DSM-5 criteria. 
Item-total correlations were also examined for each scale item within the 
individual subscales. Within the subscales, only one question within scale A1 (SE55 
‘Comes to show you something that interests him/her’) was found to have a low 
item-total correlation at r=.27. As it did not improve the Cronbach’s alpha to delete 
this item it was not removed from the interview.  
Inter-rater reliability 
Inter-rater reliability was very good for all subscales, both within the ASD 
and comparison groups separately and for the two groups combined. Intra-class 
correlations using one-way random single measures are displayed in Table 4. 
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Table 4  
Intraclass correlation coefficients 
   
 ASD Comparison  Combined 
A: Social Communication and 
Interaction 
.92 .94 .99 
A1: Social Emotional Reciprocity .96 .87 .99 
A2: Deficits in nonverbal 
behaviour used for social interaction 
.94 .98 .99 
A3: Deficits in forming, 
maintaining and understanding 
relationships 
.87 .99 .99 
B: Restricted repetitive patterns of 
behaviour, interests or activities 
.98 .90 .99 
B1: Stereotyped or repetitive 
movements 
.86 1 .92 
B2: Insistence on sameness .94 .94 .98 
B3: Restricted fixated interests .96 .81 .97 
B4: Abnormal sensory response .93 .94 .95 
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Criterion Validity 
Discrimination between ASD and comparison population 
Mean scores for the 3Di-sva subscales for the ASD group and comparison 
group are displayed in Table 5. The difference between the scores of the two groups 
was highly significant for all subscales, with very large effect sizes in all cases. 
Examination of histograms showing the distribution of scores for all 
subscales showed that for the majority of cases data was normally distributed for the 
ASD group, with the exception of scale B2 which was negatively skewed. For the 
comparison group data was positively skewed in all cases. Histograms showing the 
distribution of scores for the A-scale and B-scale are shown in Figures 3 and 4 
respectively. There was no overlap in scores between the groups on the A-scale, with 
the majority of comparison group cases scoring very low and a distribution of higher 
scores attained by the ASD group. For the B-scale, the comparison group again score 
extremely low in all cases. There is a slight overlap between ASD and comparison 
cases on this scale, with ASD group scores being distributed more evenly across the 
range of possible scores.
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Table 5 
Difference in 3Di-sva scores by group 
 
 ASD Comparison Significance of 
difference 
Effect size  
 Mean (SD) 
Range1 
Median Mean (SD) 
Range1 
Median 
A: Social Communication and 
Interaction  
3.13 (.74) 
1.65-4.48 
3.09 .32 (.24) 
.00-1.00 
.29 t(31.15)=18.73, p<.001, 
95% CI [2.50, 3.11] *** 
d=6.71 
A1: Social Emotional Reciprocity  1.07 (.27) 
.36-1.67 
1.08 .13 (.14) 
.00-.64 
.14 U=1.50, z= -6.30,  
p<.001 *** 
r=-.86 
A2: Deficits in nonverbal 
behaviour used for social interaction 
.91 (.40) 
.29-1.80 
.80 .07 (.09) 
.00-.29 
.00 U=1.00, z= -6.35,  
p<.001 *** 
r=-.86 
A3: Deficits in forming, 
maintaining and understanding 
relationships 
1.15 (.31) 
.65-1.94 
1.06 .12 (.13) 
.00-.47 
 
.12 U<.001, z= -6.33,  
p<.001 *** 
r=-.86 
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B: Restricted repetitive patterns of 
behaviour, interests or activities 
4.65 (2.36) 
.25-8.43 
4.67 .41 (.42) 
.00-1.32 
.25 U=27.50, z= -5.84, 
p<.001 *** 
r=-.80 
B1: Stereotyped or repetitive 
movements 
.68 (.47) 
.00-1.50 
.75 .03 (.08) 
.00-.25 
.00 U=66.00, z= -5.50, 
p<.001 *** 
r=-.76 
B2: Insistence on sameness 2.13 (.98) 
.00-3.33 
2.33 .15 (.23) 
.00-.67 
.00 U=43.50, z= -5.71, 
p<.001 *** 
r=-.79 
B3: Restricted fixated interests 1.06 (.64) 
.00-2.00 
1.00 .18 (.21) 
.00-.80 
.20 U=64.00, z= -5.27, 
p<.001 *** 
r=-.72 
B4: Abnormal sensory response .79 (.65) 
.00-2.00 
.80 .05 (.13) 
.00-.40 
.00 U=106.00, z= -4.87, 
p<.001 *** 
r=-.66 
Note. 1 Possible range for the A-scale is 0-6 and for the B-scale is 0-8. Possible range for subscales A1, A2, A3, B1, B2, B3 and B4 is 0-2.  *** = significant between 
group difference at p<.001.
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Figure 3. ASD group and comparison group total scores on the 3Di-sva A-scale. 
Figure 4. ASD group and comparison group total scores on the 3Di-sva B-scale. 
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Receiver Operating Characteristic (ROC)  
A ROC curve was generated to analyse the ability of the 3Di-sva A-scale and 
B-scale to discriminate between ASD and comparison participants. The ROC curve 
is displayed in Figure 5. Discriminatory ability of the two scales was assessed using 
the area under the curve (AUC), which indicated high overall accuracy of both 
scales. For the A-scale, AUC=1 (SE<.001), p<.001, 95% CI [1,1]. For the B-scale, 
AUC=.96 (SE=.02), p<.001, 95% CI [.95, 1].  
 
Sensitivity and specificity 
Cut points which maximised both sensitivity and specificity for both the A-
scale and B-scale were identified. For the A-scale (range 0 to 6) this was a scaled 
Figure 5. ROC curve of the 3Di-sva A-scale and B-scale 
Figure 5. Comparison group total score on the B-scale. 
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score of 1.4 and for the B-scale (range 0 to 8) this was a scaled score of 1. In order to 
be categorised as having ASD by the 3Di-sva a person must score above the cut-off 
on both scales (in line with DSM-5 criteria). The number of cases correctly 
categorised by the 3Di-sva is displayed in Table 6. 
Table 6 
Diagnosis according to 3Di-sva 
3Di-sva diagnosis Participant group 
 ASD Comparison 
Non-ASD 2 27 
ASD 25 0 
 
Using the above figures, sensitivity and specificity figures were calculated. 
Sensitivity (the probability that the 3Di-sva algorithm result is positive when ASD is 
present) was .93, 95% CI [.74, .99] and specificity (the probability that the result is 
negative when ASD is not present) was 1, 95% CI [0.85 – 1]. Similarly, in this 
sample the positive predictive value (the probability that ASD is present when the 
test is positive) was 1, 95% CI [.83, 1] and the negative predictive value (the 
probability that ASD is not present when the test is negative) is .93, 95% CI [.76 - 
.99]. 
Correlation between 3Di-sva scores and scores on the ADOS module 4 
Correlations between each of the 3Di-sva subscales and the ADOS module 4 
subscales are displayed in Table 7. The majority of the correlations between scores 
on the 3Di-sva subscales and the ADOS subscales were found not to be significant, 
with the exception of the correlation between the 3Di-sva B2 subscale (Insistence on 
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sameness) and the ADOS Social Interaction scale, and between the 3Di-sva B4 
subscale (Abnormal sensory response) and both the ADOS Social Interaction scale 
and the ADOS Imagination and Creativity scale. However, these correlations were 
significant at the p=.02 - .04 level and due to the large number of correlations carried 
out, may be attributable to Type 1 error.  
Table 7 
Correlations between 3Di-sva subscales and ADOS module 4 subscales for ASD 
group  
 ADOS C ADOS SI ADOS I/C ADOS 
SBRI 
ADOS 
C&SI 
A-scale  rs(27)=.15, rs(27)=.19, rs(25)=.13, rs(25)=-.06, rs(27)=.18, 
p=.45 p=.35 p=.53 p=.79 p=.38 
A1 rs(27)=.15, rs(27)=.22, rs(25)=.14, rs(25)=.02, rs(27)=.21, 
p=.45 p=.26 p=.50 p=.92 p=.30 
A2 rs(27)=.10, rs(27)=.27, rs(25)=.04, rs(25)=.01, rs(27)=.19, 
p=.62 p=.17 p=.83 p=.96 p=.34 
A3 rs(27)=.22, rs(27)=-.13, rs(25)=.11 rs(25)=-.07, rs(27)=-.01, 
p=.28 p=.52 p=.62 p=.76 p=.95 
B-scale  rs(27)=-.02, rs(27)=.35, rs(25)=.28, rs(25)=.05, rs(27)=.17, 
p=.93 p=.08 p=.17 p=.82 p=.40 
B1 rs(26)=-.03, rs(26)=.11, rs(24)=.01, rs(24)=.06, rs(26)=.07, 
p=.90 p=.59 p=.98 p=.78 p=.74 
B2 rs(27)=.05, rs(27)=.44, rs(25)=.38, rs(25)=-.05, rs(27)=.26, 
p=.81 p=.02* p=.06 p=.82 p=.20 
B3  rs(27)=-.01, rs(27)=.13, rs(25)=-.05, rs(25)=.07, rs(27)=.002, 
p=.98 p=.53 p=.80 p=.75 p=.99 
B4 rs(27)=-.17,  rs(27)=.40, rs(25)=.46, rs(25)=-.04, rs(27)=.12, 
p=.41 p=.04* p=.02* p=.84 p=.57 
Note. ADOS C = ADOS communication total; ADOS SI = ADOS social interaction total; ADOS 
I/C= ADOS imagination creativity total; ADOS SBRI = ADOS stereotyped behaviours and 
restricted interests total; ADOS C&SI= ADOS combined communication and social interaction 
total; * = significant at p<.05. 
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Construct validity 
Correlation between scores on the 3Di-sva A-scale and B-scale 
There was a significant correlation between scores on the 3Di-sva A-scale 
and B-scale for the ASD group, r(27)=.55, p=.003, and the overall sample, 
rs(54)=.79, p<.001. The correlation between scores on the two scales was not 
significant in the comparison group, rs(27)=.07, p=.72. 
Correlation between 3Di-sva score and estimated IQ 
There was not a significant correlation between scores on the 3Di-sva A-scale 
and estimated IQ for either the ASD group, r(17)=.06, p=.81, the comparison group, 
r(24)=-.08, p=.72, or the overall sample, rs(41)=-.19, p=.25. There was also not a 
significant correlation between scores on the 3Di-sva B-scales and estimated IQ for 
either the ASD group, r(17)=-.01, p=.97, the comparison group, rs(24)=-.13, p=.54, 
or the overall sample, rs(41)=-.21, p=.20. 
Gender differences in the comparison population 
There was not a significant difference between scores for males and females 
in the comparison population on the A-scale, (males: M=.37, SD=.25, Mdn=.32; 
females: M=.26, SD=.21, Mdn=2.7), t(25)=1.19, p=.25, d=.48, 95% CI [-.08, .29]. 
There was also not a significant difference in scores for males and females in the 
comparison population on the B-scale, (males: M=.41, SD=.37, Mdn=.33; females: 
M=.40, SD=.49, Mdn=.20), U=78.5, z=-.57, p=.58, r=-.11. 
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Correlation between 3Di-sva score and age 
The correlation between score on the A-scale and age was not significant for 
the ASD group, rs(27)=-.23, p=.26, or the combined groups, rs(53)=.02, p=.87, 
however it did reach significance in the comparison group, r(26)= -.42, p=.03. The 
correlation between score in the B-scale and age did not reach significance in any 
group (ASD group: rs(27)=.17, p=.41, comparison group: rs(26)= .14, p=.49, 
combined groups: rs(53)=.26, p=.07).  
Discussion 
The current study examined the psychometric properties of a new informant 
report tool for facilitating the diagnosis of ASD in adults, the 3Di-sva. The findings 
show that the 3Di-sva is a reliable instrument. The internal consistency of the 
subscales ranged from acceptable to excellent, suggesting that items within each 
subscale are sufficiently reflective of the same underlying concept. There was also a 
high level of agreement between raters for all the subscales, demonstrating that the 
3Di-sva can be consistently scored by raters, one of whom is blind to participant 
group. 
The 3Di-sva also demonstrated strong criterion related validity. Participants 
with ASD had significantly and substantially higher scores than comparison 
participants across all subscales. The high Area under the Curve, and the high 
sensitivity (93%) and specificity (100%) provide evidence that the 3Di-sva is able to 
correctly classify individuals as having ASD or not in the vast majority of cases.  
Another aspect of criterion validity examined was the correlation between 
3Di-sva subscale scores and ADOS module 4 scores for the ASD group. Three 
significant correlations were found; however the significant correlations are between 
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scales that appear to have little relationship conceptually, whereas correlations which 
may be more anticipated (e.g. between the 3Di-sva A scale and the ADOS combined 
Communication and Social Interaction scale) were not found. As noted previously, 
the significance of the correlations found could be attributable to Type 1 error due to 
the large number of correlations carried out. It is also notable that low correlations 
between the ADOS and parent report have occasionally been found elsewhere, for 
example between diagnosis on the ADOS and ADI-R (Bishop & Norbury, 2002; De 
Bildt et al., 2004). 
There may also have been a lack of power to detect other significant 
correlations between scores on the ADOS and 3Di-sva. The power achieved was 
enough to detect significance for large effects, however due to differences in the type 
of measures being compared (an informant report looking at developmental history 
and current functioning versus an observation assessing functioning at one moment 
in time), it is conceivable that smaller effects would be expected. Some of the 
correlations (e.g. between 3Di-sva A2 score ‘Deficits in nonverbal behaviour used 
for social interaction’ and ADOS Social Interaction score) did show a medium effect 
size, despite being statistically insignificant.  
In terms of construct validity, as expected there was a strong positive 
correlation between scores on the A-scale and the B-scale for the ASD group, 
suggesting that the higher symptoms are in one area, the higher they are in the other. 
This finding did not extend to the comparison group. Although it might be expected 
that some degree of traits on one scale would be related to traits on the other (albeit 
below thresholds), it appears that people without ASD scored so low on both scales 
that there was not sufficient variability to identify any correlation between them. A 
possible interpretation of this is that although the 3Di-sva provides a clear categorical 
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assessment of ASD, it is less successful in this sample at providing a dimensional 
assessment of ASD traits. 
Although a correlation between score and IQ was hypothesised, on the basis 
that a relationship between higher ASD traits and lower IQ has previously been 
demonstrated (Brugha et al., 2009), no correlation was found here for either group. 
This is a positive finding in that it suggests score on the 3Di-sva is not influenced by 
IQ. Similarly, although a relationship between score and gender in the comparison 
population was hypothesised, on the basis that traits of ASD are generally higher 
within males in the typically developing but not the clinical population (Constantino, 
& Todd, 2003; Baron-Cohen et al., 2001), no significant relationship was found. This 
may suggest that 3Di-sva score is not influenced by gender; however it should be 
noted that despite an insignificant result, a medium effect size was detected for the 
relationship between gender and A-scale score, with males generally scoring higher 
than females on this scale, again suggesting that the insignificant result could be 
attributed to lack of power to detect the effect. 
Interestingly, an unexpected significant correlation was found between age 
and 3Di-sva A-scale score in the comparison group. One possible explanation for the 
finding is that some of the ‘current’ items on the A-scale may pick up behaviours 
towards parents that may be considered fairly normal in some young adults, such as 
‘Does [name] have conversations with you just to be sociable, for instance, does s/he 
made small talk?’. It was found that parents of younger participants occasionally 
noted that their child did not, but they felt it was an expected phase of behaviour. 
This could explain why older comparison participants scored lower on this scale 
overall. This is not however a problem for the validity of the 3Di-sva, as despite 
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slightly higher A-scale scores for younger comparison participants, all comparison 
participants scored lower on this scale than ASD participants.  
As well as the criterion and construct validity investigated here, it appeared 
that participants in the ASD group subjectively felt the 3Di-sva had good face 
validity. Although this was not formally measured, informants often commented 
when asked that they felt the interview had covered all their areas of concern in 
relation to a possible diagnosis of ASD. The 3Di-sva also has good content validity, 
as it was designed to represent all the DSM-5 ASD diagnostic criteria. It is notable 
however that the content of the interview is weighted towards to the A-scale, with the 
B-scale subscales having many fewer items than those in the A-scale. This was 
controlled for by creating weighted scale scores, however as the B-scale subscales 
also demonstrated slightly lower (although still acceptable) internal consistency, it 
may be helpful to investigate whether this can be improved by the addition of further 
items within the B-scale. This is an issue which does not affect the 3Di-sva alone; 
other ASD diagnostic tools used with adults such as the ADOS module 4 and ADI-R 
also include more social and communication items than repetitive and stereotyped 
behaviour items. There a general need to improve the measurement of repetitive and 
stereotyped behaviour in adult ASD diagnostic tools. 
It is notable that the 3Di-sva would have had perfect sensitivity and 
specificity if using A-scale score alone to indicate diagnosis, as opposed to meeting 
the threshold on both the A-scale and B-scale. The two cases that were not correctly 
classified by the 3Di-sva were missed on the basis of a low score on the B-scale. It 
was considered important that individuals met the threshold on both scales when 
considering sensitivity and specificity, as DSM-5 criteria requires individuals to have 
experienced symptoms in both areas. There is known to be group of individuals who 
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display only the social reciprocity and communication deficits  seen in ASD without 
the significant repetitive and stereotyped behaviours (Mandy, Charman, Gilmour & 
Skuse, 2011), and the DSM-5 introduced a new diagnosis for such cases: Social 
Communication Disorder (SCD). Although the two cases in question here did receive 
a diagnosis of ASD, it is possible that SCD could be a more suitable diagnosis. 
Nonetheless, one could argue that when used in clinical practice, a score above cut-
off on both the A-scale and B-scale could be taken as a strong indication of a positive 
diagnosis of ASD, with cases which score above cut-off on the A-scale but not B-
scale also indicating possible diagnosis of ASD. Cases that do not score above cut-
off on the A-scale (even if they do on the B-scale) should be considered highly 
unlikely to indicate a positive diagnosis of ASD. 
The fact that B-scale score was less sensitive to diagnosis of ASD than A-
scale score may be related to the idea that in an adult population, the DSM-5 criteria 
of Restricted, Repetitive Patterns of Behaviour, Interest or Activities are less 
persistent. It has been found that adults are likely to show less restricted and 
repetitive behaviours and interests symptoms whilst displaying the same 
communication symptoms as younger cohorts (Seltzer et al., 2003), and that 
prevalence of symptoms related to social reciprocity and non-verbal communication 
are generally higher than symptoms of repetitive behaviours and stereotyped interests 
in adults (Shattuck et al., 2007). For this reason it may be helpful to focus any new 
B-scale questions on behaviours that may have been present during childhood rather 
than current behaviours; or to get a better understanding of how this aspect of ASD 
manifests in adulthood. 
The current research also confirms that the 3Di-sva is a time and resource 
efficient tool suitable for use within ASD diagnostic clinics. Within the ASD group, 
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length of the interview varied between 23 and 75 minutes, with the mean length of 
interview being 50 minutes. Interviews were successfully conducted both in person 
and on the telephone, meaning that parents who were unable to attend clinic 
appointments were still able to be interviewed. All researchers and clinicians who 
took part in the study, including the psychology undergraduate who carried out 
scoring for inter-rater reliability purposes, received around one hour of instruction in 
its use, showing that training on the 3Di-sva is quick and straightforward. 
Limitations and future directions 
 One limitation of the current research is that it does not include a comparison 
group with other clinical diagnoses. As we know that ASD is associated with 
extensive comorbidity (Mukaddes et al., 2010) and people with ASD can display 
similar features to other disorders (Baastiansen et al., 2011, Zandt et al., 2009), a 
more difficult and ecologically relevant test of the 3Di-sva would be to examine its 
ability to discriminate adults with ASD from those in other clinical populations. It is 
necessary to test the 3Di-sva in populations with psychosis, anxiety, and depression, 
whose presentations may include features and symptoms that could potentially be 
picked up by the 3Di-sva, for example difficulties with social interactions and 
restricted behaviours. Such research has already begun, as the current research was 
conducted as part of a joint project and McKenner (2015) reports on the 3Di-sva 
when used with a clinical control group. However this research contains participants 
with a mixture of different disorders such as anxiety, depression, psychosis and 
personality disorder. This could be extended further by comparing clinical control 
groups with separate diagnoses in order to provide information on the diagnostic 
utility of the 3Di-sva in specific clinical areas. 
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 The current research was restricted by the fact that the time was not available 
to investigate test retest reliability. In order to ensure that the 3Di-sva provides a 
reliable measure of ASD symptoms across time, there is a need for the future 
analysis of test retest reliability. This could be done by approaching the current 
sample and conducting the 3Di-sva again with the same informant. Another 
additional factor to investigate in future research would be the correlation between 
the 3Di-sva and other tools purporting to measure ASD symptoms. Although limited 
correlation was found with the ADOS module 4 in the current research, it would also 
be interesting to further investigate the validity in respect to the 3Di-svas relationship 
to other types of instruments such as self-report (e.g. RAADS-R) and other informant 
report (e.g. ADI-R) tools. 
 As previously alluded to, the relatively small sample size has been somewhat 
of a limitation in this research. The sample size was enough to detect large effect 
sizes, and we were able to clearly demonstrate the criterion validity of the 3Di-sva in 
terms of its ability to accurately distinguish between groups. However, as discussed 
above, it is possible that some of the other hypotheses were rejected as a result of not 
enough power to detect smaller effects. Future research with a larger sample size 
may help reach clearer conclusions about these effects. Additionally, the current 
sample did not allow for investigation of internal consistency of the scales for 
separate groups, due to the very low variance within groups amongst some of the 
subscales, particularly in the comparison group. A large sample size would likely 
lead to more variance, allowing a valid demonstration of internal consistency in the 
separate populations. Furthermore, a larger sample size would be of benefit in terms 
of further analysing the construct validity of the 3Di-sva using factor analysis. It is 
also worth noting that only 10 ASD and 15 comparison cases were audio-recorded 
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and therefore included in the inter-rater reliability analyses; this is a small number 
and so results should be treated with some degree of caution. Similarly, the relatively 
small sample size could affect the precision of the estimates of sensitivity and 
specificity. Further investigation of these factors in a larger sample would be of 
value. 
 It is acknowledged that there was a lack of formal screening for symptoms of 
ASD or mental health difficulties in the control group, due to the limited time and 
financial resources available. It would be of benefit for future research of the 3Di-sva 
to include tools such as the AQ, Generalised Anxiety Disorder Assessment (GAD-7; 
Spitzer, Kroenke, Williams & Löwe, 2006) and Patient Health Questionnaire (PHQ-
9; Spitzer, Kroenke & Williams, 1999) to measure self-reported symptoms of ASD, 
anxiety and depression respectively. Participants were asked whether they 
experienced any symptoms of ASD or mental health difficulties when screening for 
eligibility, but it is possible that participants could be unaware of or unwilling to 
directly report any such symptoms. I would argue however that any presence of 
unreported ASD or mental health symptoms would make it more difficult to 
demonstrate the between-group differences found here, suggesting the presence of 
any such symptoms would not affect the validity of the conclusions reached.  
Another potential confound to acknowledge is that we did not explore 
whether the method of administration (i.e. in person versus telephone) or who acted 
as the informant (i.e. mother versus other informant) influenced the results. The vast 
majority of informants in both groups were mothers, meaning there was not 
sufficient variability to investigate differences in outcomes depending on informant. 
The majority of comparison group interviews were done over the phone, whereas the 
number of interviews completed in person versus on the phone in the ASD group 
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was more equal across the cases for which method of administration was known. As 
we cannot be certain of the method of administration in the historical ASD group 
cases, which make up half of the ASD group, there were not sufficient numbers with 
which to analyse any differences related to method of administration. Due to the 
highly structured nature of the 3Di-sva, it is unlikely that method of administration 
would influence outcome, and subjectively there appeared to be no difference in 
interviews conducted in person and on the phone. However, it would be worth 
investigating whether these variables affect the results in the future, using a larger 
sample. 
Implications and Conclusions 
This research has shown that 3Di-sva is a potentially useful tool as part of an 
ASD assessment for adults. It has proved to be reliable, in terms of good internal 
consistency and high inter-rater reliability, as well as highly accurate at 
discriminating between individuals with and without ASD. It is also a time and cost 
efficient tool, which is easy to administer and score. It provides an indication of 
diagnosis according to DSM-5 criteria, allowing for assessment of symptoms across 
the range of the DSM-5 criteria. The 3Di-sva could be used as part of a multi-
dimensional assessment, providing valuable informant report information alongside 
other sources of information such as observation using the ADOS module 4.  
As previously discussed, informant report is an important source of 
information, which should be included whenever possible when carrying out an adult 
ASD assessment. The 3Di-sva has potential to be an improvement on other currently 
available NICE (2012) recommended informant report tools, namely the ADI-R, 
AAA, ASDI and DISCO. This research has provided good initial evidence for the 
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psychometric properties of the 3Di-sva; evidence which is lacking for the other tools. 
Additionally the time and cost efficiency makes the 3Di-sva more suitable for use in 
clinics with limited resources than the ADI-R and DISCO, and it is the only known 
informant report tool currently available which assesses adult ASD in line with 
DSM-5 criteria. 
This research is the first step in validating the instrument and further work to 
continue to demonstrate its usefulness is still required. It would be helpful to 
complete further research using a larger sample size, and it is essential that test-retest 
reliability and ability to discriminate between different clinical control groups is 
investigated. 
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Introduction 
This critical appraisal extends the discussion of both my literature review and 
empirical paper, reflecting on two main areas of the research process which have 
been challenging and thought-provoking. The first is that of ideal versus achievable 
research, in which I consider how my own study led me to recognise the difficulties 
faced in achieving the ideals I set up within my literature review for autism spectrum 
disorder (ASD) diagnostic tool research. The second is a reflection on my learning 
process about research within NHS settings, including how my expectations for 
others’ roles within my research did not fit with reality, but how this ultimately 
benefitted me in terms of my own appreciation for and understanding of the 
Developmental, Diagnostic and Dimensional Interview - Short Form Adult Version 
(3Di-sva). 
Ideal versus achievable research 
Following my literature review, it was of interest to me that no study I 
reviewed fulfilled all the quality criteria outlined in the critical appraisal tool used 
(the BMJ Critical Evidence (2014) tool), and several studies fulfilled troublingly few.  
I was surprised at the poor quality of some of the research, and concluded the review 
with remarks about what an ideal study into an ASD diagnostic tool would consist of. 
I feel it is important for me to reflect upon how I experienced the reality of 
completing my own research into an ASD diagnostic tool and how this links to the 
literature I reviewed. 
The literature review was beneficial in aiding my thinking about the design of 
my own study, highlighting some of the shortfalls present in existing research and 
helping me to hold in mind the important and desirable factors for mine. My study 
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met the majority of the criteria within the critical appraisal tool used for the literature 
review; however it did fall short of the ‘ideal’ study described in two main ways. The 
first was the lack of a clinical control group and the second was a measure of test-
retest reliability. Completing my own research allowed me to better comprehend 
some of the barriers that appear to be limiting the standard of research often 
produced in this area, particularly in relation to research on informant report tools. 
Recruiting participants 
It became apparent that, whilst recruiting ASD participants for the research 
was fairly straightforward, raising the interest of people without ASD to take part 
was considerably more challenging. Not only were we asking individuals to 
participate in research on a topic to which they necessarily had no association (as it 
was a requirement that comparison participants did not suspect they had traits of 
ASD), we were also asking them to recruit someone else to take part in it too – as 
research on informant reports inevitably requires both the individual and an 
informant to agree to take part. In an attempt to gain the interest of non-ASD 
participants we began by offering a £5 voucher for their time. We quickly became 
aware however that this was not enough of an incentive and raised this to £10. The 
higher amount did result in more non-ASD participants coming forward, however 
this then constrained the total number of people we could recruit due to financial 
limitations.  
Recruitment of non-clinical comparison participants was a challenge, yet I 
have posited in both my literature review and my empirical paper that it is also 
essential that research of ASD diagnostic tools demonstrates the validity of the 
instrument when used with different clinical control populations. Within clinical 
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control populations it is likely that recruitment would be even more difficult, as not 
only is ASD again a condition unrelated to the person, but the individuals in question 
are also likely to have their own set of significant difficulties and challenges to focus 
on. Potential participants could also be put off taking part if they do not want their 
parent to know that they are receiving mental health treatment. Recent or current 
illness is cited as a factor which adversely affects recruitment of research participants 
(Patel, Doku &Tennakoon, 2003), with the level of additional demand put upon 
patient participants influencing their decision to take part in research (Ross et al., 
1999). It seems probable that the more impaired someone is by their mental health 
difficulties the less likely they are to be interested in participating in something that 
offers very little in return to them, especially given the additional burden of needing 
to seek participation from another person as well as themselves.  
My insight into the reality of recruiting control populations helps me 
comprehend why many of studies reviewed presented data in which the clinical 
control population consisted of individuals who were assessed for ASD but found to 
have a mental health rather than ASD diagnosis, instead of being recruiting from 
specific mental health populations. Only one study (on the ADOS module 4, 
Bastiaansen et al., 2011) investigated the diagnostic tool when used with separate 
clinical control populations (schizophrenia and personality disorder), despite that fact 
that it is important to understand the validity of ASD diagnostic tools within separate 
diagnostic populations. Without such research we cannot uncover potential variations 
in the validity of the diagnostic tools in different clinical populations, which will be 
masked when a comparison group consists of such a diverse mix of diagnoses. 
However whilst we can identify that this is ideal, and indeed necessary, the reality is 
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that with the difficulties in recruiting for such studies, research is published using 
whatever type of control group has been achievable. 
A lack of the funding needed to compensate participants from control groups 
is not confined to ASD diagnostic tool research completed as a part of a doctoral 
thesis. In the current economic climate money for research is something that can 
often be hard to secure. The Autism Alliance (2015) note that finance for ASD 
research is often assigned to specific areas such as genetics and early intervention, 
plus only 30% of all ASD research funding goes to work focussed on adults. Patel et 
al., (2003) suggest that participants conduct a personal cost-benefit analysis when 
deciding when to take part in research. Although some benefit may be gained, for 
example enjoyment of the contact with researchers, it is likely that costs involved in 
taking part in this type of research exceed the benefits for control group participants, 
unless they receive suitable financial compensation. It is perhaps simplistic to think 
that more funding is the answer to the difficulties in recruiting control groups, but my 
experience did indicate that individuals are somewhat more willing to give up their 
time if they do get something in return. 
As having comparison groups is essential to proving the validity of any ASD 
diagnostic tool, I envisage that the difficulty of recruiting these groups has been a 
significant barrier to more studies being published on the existing tools. Of the 
National Institute of Clinical Excellence (NICE; 2012) recommended informant 
report tools, only the ADI-R has more than one paper published examining its use in 
adults. This highlights the fact that more interest and funding is needed for this area, 
especially if we are to improve diagnostic services for adults with ASD, as 
recommended in the Strategy for Adults with Autism (Department of Health, 2010). 
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Reference standards 
A dilemma that I came across during my research is the difficulty of having a 
suitable reference standard against which to judge the sensitivity and specificity of an 
ASD tool. The ideal reference standard would be an expert clinician consensus 
diagnosis of ASD made according to the DSM-IV (American Psychiatric Association 
(APA), 2000), DSM-5 (APA, 2013) or ICD-10 (World Health Organisation, 1992) 
criteria. The majority of papers reviewed in the literature met this criterion, as did all 
cases included in my research. However, even when this ideal reference standard is 
in place, an issue of circularity arises if information gleaned from the instrument 
under investigation is used when making such diagnoses. This issue was present in 
some of the papers included in the literature review (Baron-Cohen, Wheelwright, 
Robinson & Woodbury-Smith, 2005; Hus & Lord, 2014). In my own research, 
although 3Di-svas completed for the study were not scored at the time of the 
assessment, we could still have been criticised for including information obtained 
during the 3Di-sva interview when making diagnostic decisions.  We therefore set 
the criterion that research participants first had to meet criteria for a diagnosis 
according to the ADOS module 4. Following this, to rule out false positives on the 
ADOS and ensure diagnoses were made according to DSM-5 criteria, the diagnosis 
was also confirmed by clinician consensus opinion. The ADOS criterion protected us 
from the issue of circularity, but brought with it its own complications. 
Having the ADOS score criteria meant that we lost cases from the ASD group 
who did receive a diagnosis of ASD but did not score up on the ADOS. The ADOS 
itself, although often considered to be ‘gold standard’, is not a perfect measure. As 
noted in the literature review, the overall sensitivity and specificity demonstrated 
across the available ADOS module 4 papers (Bastiaansen et al., 2011; Brugha et al., 
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2012; Hus & Lord, 2014; Lord et al., 2000) suggest a sensitivity and specificity of 
around 89% and 84% respectively. Therefore cases who did have ASD, but whose 
symptoms were more subtle or better masked during a one-off observation, were 
excluded from the analysis. This raised concerns for me that we were only allowing 
the cases with a clearer diagnosis of ASD to be included in our analysis, which 
makes it easier to demonstrate high sensitivity and specificity. For my own peace of 
mind I did score the cases for which I had data but were excluded on this basis and 
found that they would have scored above the 3Di-sva thresholds according to those 
set in the empirical paper; however it still seems somewhat unsatisfactory to need to 
exclude these cases. 
  As an ideal, to overcome these issues, the 3Di-sva would have been used on a 
group of participants who had received a diagnosis of ASD according to DSM-5 
criteria, without the 3Di-sva having been part of the diagnostic process. However this 
again raises issue of what is ideal versus what is achievable. In this situation we did 
not have the capacity to complete 3Di-svas, in addition to another interview or 
instrument that would have been necessary to include in its place, to reach diagnostic 
conclusions. It was therefore felt that the inclusion criteria set were the optimal way 
of controlling for the issues around reference standard and circularity that arose.  
Measuring cognitive ability 
In line with one of the criteria in the appraisal tool used for the literature 
review, it was considered essential to include an estimate of participant IQ in my 
research, in order to understand and control for any influence of IQ on 3Di-sva score. 
It was clear that it would not be practicable to complete a full WAIS-IV (Wechsler, 
2008) with each participant, and after careful consideration it was also felt that 
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completing the WASI (Wechsler, 1999), which takes between 15 and 30 minutes 
depending on the number of subtests used, would also not be realistic. The Test of 
Premorbid Functioning (TOPF, Wechsler, 2009), an updated version of the Wechsler 
Test of Adult Reading (WTAR; Wechsler, 2001) which takes around five minutes to 
complete and requires few materials, was eventually chosen as the most feasible 
instrument given the time and financial restrictions. The TOPF score, along with 
demographic information, is used to predict full scale IQ on the WAIS-IV.  
However, the TOPF is a tool designed to predict premorbid intellectual 
function, when there is a suspected loss of cognitive function. This was not the case 
in the majority our sample, although it was believed that this could be helpful in the 
clinical control cases (reported on by McKenner, 2015) as it is known that cognitive 
function can be affected by mental health difficulties (McDermott & Ebmeier, 2009; 
Michel et al., 2013). It should however be acknowledged that our method of 
estimating IQ was not perhaps the ideal choice to use across all participants and 
should we have had unlimited time, finances and enthusiasm from participants, the 
WASI or WAIS-IV would be used. However, this is where a compromise had to be 
made and a feasible method of estimating of IQ was certainly better than none at all.  
In some cases it proved challenging to even complete the TOPF (a very quick 
measure which simply involves reading out a list of words) with all participants. This 
was often the case in the ASD group, where I was frequently given cases to complete 
a 3Di-sva over the phone, meaning my first chance to complete a TOPF with the 
participant was when they attended their diagnostic feedback session. Due to the 
often emotive nature of such an appointment, it was important that I had a test that 
was quick and undemanding. I consequently think that we would have been less 
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successful in gaining the data we needed had we chosen the WASI, and therefore 
under the circumstances made the correct decision. 
Unacceptable compromise 
My own research enabled me to sympathise with the difficulty of achieving 
some of the study features required for a high score according the critical appraisal 
tool, and highlighted that sometimes compromises have to be made. However it has 
also strengthened my assertion that some of studies examined in the literature review 
are not of suitable quality, based on the currently available evidence, to be 
recommended for use. It seems reasonable to expect studies to publish data on the 
majority of the psychometric properties added to the critical appraisal tool if they are 
to be used in clinical practice. My research failed to measure just one from the list, 
test retest reliability, which required more time to investigate than was available. 
However it seems inexcusable that straightforward data such as internal consistency 
and association with participant characteristics (e.g. correlation between scores and 
age or IQ) is not reported in some studies on ASD diagnostic tools. Such statistics 
are vital to investigate before we can go on to conclude on the validity of an 
instrument.  
During the course of my research I have become more aware of the 
diagnostic process used within different NHS diagnostic clinics. Although both 
clinics I was involved with used clinical interview, ADOS module 4 and the 3Di-sva, 
other services base their diagnostic decisions on the AAA (Baron-Cohen et al., 
2005), on the basis that the AAA describes itself to be a complete diagnostic system 
and is recommended by NICE (2012). However when one considers that there is no 
data published regarding any form of reliability for the AAA, this does begin to seem 
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less than ideal. It troubles me that some instruments recommended by NICE (2012) 
and used by NHS diagnostic services are ones which we can’t yet be sure are reliably 
measuring the concept they claim to measure. I am aware that research into adult 
ASD diagnostic tools is a relatively new and under researched  area, and I hope that 
over time research in this area develops further, giving us a clearer evidence base 
upon which to select our diagnostic tools. 
Research within NHS diagnostic clinics 
Another area I would like to reflect upon is that of the realities of completing 
research within NHS settings, particularly when you are not working within the 
particular setting you are recruiting from. As someone who would like to continue 
clinical research post qualification, the experience of completing my empirical paper 
has been an important lesson in managing expectations when completing research 
within the NHS. I believe this is important to consider, as the expectations I had upon 
others at the start of my research proved to be too high and this led to significant 
delays in the data collection that could have otherwise been avoided. Not only was 
my recruitment far more successful once I changed my expectations, being made to 
change my approach was also beneficial for my own understanding of the 3Di-sva. 
High expectations 
We began with just one ASD recruitment site, and it was initially 
conceptualised that my research partner and I would be required to spend little time 
at the ASD clinic and instead would focus our efforts on recruiting those from the 
comparison groups. The rationale was that the ASD group data would, with the 
agreement of the clinic lead and the assistance of clinicians at the service, ‘collect 
itself’. The 3Di-sva had already become incorporated into the standard clinic 
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assessment process, and therefore the only additional elements needed on top of the 
normal procedure was for clinicians to get signed consent, complete the TOPF, and 
audio-record their 3Di-sva assessment. Each of these tasks seemed, to me, to be 
relatively quick and straightforward. However, over a period of many months’, data 
was collected for just two people (without audio-recordings), despite the fact that 
many more assessments had been completed. It became clear that expecting the 
clinic to collect what we needed on our behalf was not going to work, and so I began 
attending the service on a weekly basis to collect data myself. This approach was far 
more successful, as across the course of 12 weeks I was able to complete and record 
13 3Di-sva interviews (of which eight were eligible for inclusion in the ASD group). 
Had I taken this approach from the start, the number of participants we had been able 
to recruit overall would have been significantly higher. 
This situation highlighted to me that we had expected too much of the ASD 
clinic. The expectations were formed following discussions with and agreement from 
the head of the clinic, and as outsiders to the service it had seemed like relatively 
little to ask clinicians to include a few additional steps in their routine in order to 
collect our data. However, for clinicians in a busy service that runs only one day a 
week, expecting them to hold our research in mind and complete any additional tasks 
was not realistic. My expectation was that clinicians would be on board with the data 
collection as they would benefit from the 3Di-sva being validated and having 
diagnostic thresholds. However I came to understand that, despite the fact that I saw 
my research as important and interesting, this did not mean clinicians would feel the 
same way when their main task is to get through a waiting list of patients to meet 
targets set by NHS service commissioners. Furthermore, the clinic itself went 
through a long period of change and upheaval, with the physical location of the clinic 
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moving and a great deal of staff change, making our research even more of a burden 
for them and something even less at the forefront of their minds. 
Due to the difficulties of recruiting from the first site, we added a second 
ASD site, which did successfully collect data itself. This clinic was headed by one of 
the co-supervisors of the project, who had worked at the first clinic at the point that 
the project was begun. This clinic was smaller and was not experiencing any 
upheaval. In this case, the clinic was able to successfully collect data for us without 
me needing to be physically present at the service. Unfortunately we only began 
using this site many months into the research, and the assessment process was slower 
as it was smaller clinic, meaning we recruited few participants from the site.  
Overall I have taken from this experience that recruiting within NHS services 
is likely to be most successful if you are collecting data within the service yourself, 
and if not there ideally needs someone else within the clinic with a vested interested 
in the project. NHS clinics are busy environments with many targets to meet, and 
expecting others to take on extra tasks for the benefit of an outsider researcher is 
unlikely to be a feasible approach. 
Benefits of greater involvement 
 Although my significantly increased involvement in collection of the data for 
the ASD group came at the price of a reduced ability to be involved in collection of 
the data for the clinical control group (reported on by McKenner, 2015), I appreciate 
now that I would have missed out on the important experience of using the 3Di-sva 
as a clinician within an ASD diagnostic clinic, had I not had to re-think my 
recruitment strategy. Completing a number of 3Di-svas with the ASD group, as well 
as participating in team meetings and diagnostic discussions, enabled me to take a 
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scientist-practitioner role in my research, gaining an important first hand 
understanding of using the instrument as a clinician within the population for which 
it is intended. Using the tool with the ASD population proved to me that for a 
clinician in a diagnostic clinic, it is a suitable and user-friendly tool.  
I also came to realise that had I only conducted the interviews with the non-
clinical and clinical control groups I would have been less aware of questions which 
are occasionally misinterpreted or hard to score within the ASD population. Many of 
the questions are less relevant and therefore more easily scored as ‘behaviour not 
present’ in the control populations, so collecting data solely from these would have 
meant I was less aware of areas needing scoring clarification. Gaining this 
understanding was essential in terms of writing a scoring manual with which to train 
others, which in turn is vital to ensure the high inter-rater reliability of the 
instrument. 
Interviewing the parents of the ASD group also enabled me to form 
conclusions about the face validity of the instrument. After completing the 3Di-sva I 
had a chance to informally discuss with informants whether they felt the relevant and 
important areas had been covered. I was reassured to hear consistently they had been. 
Had I not repeatedly used the instrument with the ASD population, I could not have 
reached such a conclusion.  
I also felt very positive from using the 3Di-sva myself within the service, and 
participating in team discussions around diagnoses, that the 3Di-sva was indeed a 
useful adjunct tool, that was generally easy to complete, and provided necessary and 
helpful information needed when making diagnostic decisions. This in turn has 
further increased my passion for continued investigation of the tool, as I feel 
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convinced that the clinical implications of this research genuinely are that this tool 
could be of great benefit to ASD diagnostic services. 
Concluding remarks 
 The process of completing my literature review and empirical paper has been 
both challenging and rewarding. It has been an interesting process to begin by 
reviewing literature and forming conclusions about how ASD diagnostic tool 
research should be done, to then personally experience the difficult reality of 
completing such a study. I have learnt that a lot of determination and flexibility are 
needed to complete studies within clinical settings, but that ultimately such research 
is worthwhile. I have been able to experience first-hand the benefits of taking a 
scientist-practitioner role, combining clinical work and research. Seeing the value of 
the tool I was researching first-hand preserved my determination and enabled me to 
remain motivated in the face of the inherent challenges. 
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BMJ Clinical Evidence (2014) tool for critically appraising diagnostic test 
studies. 
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REFERENCE STANDARD 
Was there a clear question for the study to address? 
[Is all the following information included in the paper?] 
 YES NO UNCLEAR 
Population    
Test    
Setting    
Outcome    
 
Is there comparison with an appropriate (gold) reference standard for diagnosing ASD? I.e. 
DSM or ICD. 
 YES NO UNCLEAR 
    
 
SAMPLE [additional question] 
Does the study include an adequate sample size for analysis?  
[Arbitrary but defined here at least 20 ASD and 20 non-ASD] 
 YES NO UNCLEAR 
    
 
POPULATION 
Did the study include people with other disorders that are commonly confused with ASD? 
 YES [separate 
clinical comparison 
group] 
NO UNCLEAR [combined 
in one comparison 
group within non-
clinical controls – 
score 0.5] 
    
 
BLINDING 
Were the people assessing the results of the index diagnostic test blinded to the results of the 
reference standard? 
 YES NO UNCLEAR/PARTIAL 
[Score 0.5 if partial 
blinding] 
    
 
TESTING 
Was the reference standard applied regardless of the index test result? 
[This question is used to discriminate studies which used the index test to inform the 
reference standard] 
 YES NO UNCLEAR 
    
 
CONFOUNDS [additional question] 
Was a measure of cognitive ability used with at least part of the each group? 
 YES NO UNCLEAR 
    
 
 
 
Was the diagnostic test validated in a second independent group of patients? 
[Was the sample collected from more than one site?] 
 YES NO UNCLEAR 
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METHODS 
Were the methods of the diagnostic test described in enough detail? 
 
Rationale for the reference standard? 
[Automatically given a 1 if gold standard (DSM/ICD) but scored for those with alternative 
reference standard that therefore needs explaining] 
 YES NO UNCLEAR 
    
 
 
Technical specifications or references for running the index test and reference standard? 
[Sufficient detail to replicate study] 
 YES NO UNCLEAR 
    
 
Methods for calculating or comparing measures of diagnostic accuracy? 
[Question used to show if the method of statistical analysis is described] 
 YES NO UNCLEAR 
    
 
 
Results – what should ideally be included? 
POPULATION 
 
Are there sufficient clinical and demographic characteristics of the people in the study? 
[Need to include age (mean, standard deviation and range) and gender. If one of these is 
missing then marked as partial and score as 0.5] 
 YES NO UNCLEAR/PARTIAL 
    
 
Do the results include how indeterminate results, missing results and outliers of the index 
test were handled? 
 YES NO UNCLEAR 
    
 
Do results include criteria for defining severity of the target disorder? 
 YES NO UNCLEAR 
    
 
Do the results include cross-tabulation of the index test results by the reference standard 
results? Or is there enough information to generate this? 
 YES NO UNCLEAR 
    
 
 
Do the results include estimates of diagnostic test accuracy? 
 YES NO UNCLEAR 
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Do the results include important psychometrics? [additional question] 
Inter-rater reliability 
 YES NO UNCLEAR 
    
Test-retest reliability 
 YES NO UNCLEAR 
    
Internal consistency 
 YES NO UNCLEAR 
    
Convergent validity    
 YES NO UNCLEAR 
    
Correlation with participant characteristics 
 YES NO UNCLEAR 
    
 
TOTAL SCORE:  
 
Note. Questions in blue represent additional questions added to original tool. Remarks in 
grey clarify the question and how to score it where necessary. 
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APPENDIX 2 
Scoring of each paper using the modified BMJ Critical Appraisal Tool 
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Modified BMJ Critical Appraisal Tool Question Paper 
 RAADS/-R AAA 
 Anderson et al. 
(2011) 
Ritvo et al. (2008) Ritvo et al. (2011) Baron-Cohen et al. 
(2005) 
Was there a clear question for the study to address?     
Population 1 1 1 1 
Test 1 1 1 1 
Setting 1 1 1 1 
Outcome 1 1 1 1 
     
Is there comparison with an appropriate (gold) reference 
standard for diagnosing ASD? I.e. DSM or ICD? 
0 1 1 1 
     
Does the study include an adequate sample size for 
anaylsis? 
1 1 1 0 
     
Did the study include people with other disorders that are 
commonly confused with ASD? 
0.5  1 1 0 
     
Were the people assessing the results of the index 
diagnostic test blinded to the results of the reference 
standard? 
0 0 0 0 
     
Was the reference standard applied regardless of the 
index test result? 
1 1 1 1 
     
Was a measure of cognitive ability used with at least part 
of the each group? 
1 0 1 0 
     
Was the diagnostic test validated in a second independent 
group of patients? 
1 1 1 0 
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Rationale for the reference standard? 0 1 1 1 
     
Technical specifications or references for running the 
index test and reference standard? 
1 1 1 1 
     
Methods for calculating or comparing measures of 
diagnostic accuracy? 
1 1 1 0 
     
Are there sufficient clinical and demographic 
characteristics of the people in the study? 
1 0 0.5 0.5 
     
Do the results include how indeterminate results, missing 
results and outliers of the index test were handled? 
1 0 0 0.5 
     
Do results include criteria for defining severity of the 
target disorder? 
0 0 0 0 
     
Do the results include cross-tabulation of the index test 
results by the reference standard results? Or is there 
enough information to generate this? 
0 1 1 1 
     
Do the results include estimates of diagnostic test 
accuracy? 
1 1 1 0 
     
Do the results include important psychometrics?     
Inter-rater reliability 0.5 0.5 0.5 0 
Test-retest reliability 1 0 1 0 
Internal consistency 1 1 1 0 
Convergent validity 1 0 1 0 
Correlation with participant characteristics 1 1 1 0 
     
TOTAL 18 16.5 20 10 
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Modified BMJ Critical Appraisal Tool Question PAPER 
 ADOS 
 Bastiaansen et al. 
(2011) 
Brugha et al (2012) Hus & Lord (2014) Lord et al. (2000) 
Was there a clear question for the study to address?     
Population 1 1 1 1 
Test 1 1 1 1 
Setting 1 1 1 1 
Outcome 1 1 1 1 
     
Is there comparison with an appropriate (gold) reference 
standard for diagnosing ASD? I.e. DSM or ICD? 
1 0 1 0 
     
Does the study include an adequate sample size for 
analysis? 
1 0.5* 1 0 
     
Did the study include people with other disorders that are 
commonly confused with ASD? 
1 0 1 0.5 
     
Were the people assessing the results of the index 
diagnostic test blinded to the results of the reference 
standard? 
0.5 0 0 1 
     
Was the reference standard applied regardless of the 
index test result? 
1 0 0 1 
     
Was a measure of cognitive ability used with at least part 
of the each group? 
1 0 1 1 
     
Was the diagnostic test validated in a second independent 
group of patients? 
1 0 1 1 
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Rationale for the reference standard? 1 1 1 0 
Technical specifications or references for running the 
index test and reference standard? 
1 1 1 1 
     
Methods for calculating or comparing measures of 
diagnostic accuracy? 
1 1 1 1 
     
Are there sufficient clinical and demographic 
characteristics of the people in the study? 
1 0 1 1 
     
Do the results include how indeterminate results, missing 
results and outliers of the index test were handled? 
1 0 1 1 
     
Do results include criteria for defining severity of the 
target disorder? 
0 1 0 1 
     
Do the results include cross-tabulation of the index test 
results by the reference standard results? Or is there 
enough information to generate this? 
0 1 0 1 
     
Do the results include estimates of diagnostic test 
accuracy? 
1 1 1 1 
     
Do the results include important psychometrics?     
Inter-rater reliability 1 0.5 1 1 
Test-retest reliability 0 0 0 0 
Internal consistency 1 0 1 0 
Convergent validity 0 1 0 0 
Correlation with participant characteristics 1 0 1 1 
     
TOTAL 19.5 12 18 17.5 
* N.B. 618 participants completed ADOS module 4. However sensitivity and specificity analyses were conducted on subset of n=56 and >20 received an ASD diagnosis. 
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Modified BMJ Critical Appraisal Tool Question PAPER 
 ASDI ADI-R ADOS/ADI-R (LD) DISCO/ADI-R 
 Gillberg et al. 
(2001) 
Lord et al. (1997) Sappok et al. 
(2013) 
Nygren et al. 
(2009) 
Was there a clear question for the study to address?     
Population 1 1 1 1 
Test 1 1 1 1 
Setting 1 1 1 1 
Outcome 1 1 1 1 
     
Is there comparison with an appropriate (gold) reference 
standard for diagnosing ASD? I.e. DSM or ICD? 
1 0 1 1 
     
Does the study include an adequate sample size for 
analysis? 
0 1 1 (ADOS) 
0 (ADI-R) 
0 
     
Did the study include people with other disorders that are 
commonly confused with ASD? 
0.5 0.5 1 0.5 
     
Were the people assessing the results of the index 
diagnostic test blinded to the results of the reference 
standard? 
1 0.5 1 1 
     
Was the reference standard applied regardless of the 
index test result? 
1 1 1 1 
     
Was a measure of cognitive ability used with at least part 
of the each group? 
1 1 0 1 
     
Was the diagnostic test validated in a second independent 
group of patients? 
0 1 0 0 
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Rationale for the reference standard? 1 0 1 1 
Technical specifications or references for running the 
index test and reference standard? 
1 1 1 1 
     
Methods for calculating or comparing measures of 
diagnostic accuracy? 
0 1 1 1 
     
Are there sufficient clinical and demographic 
characteristics of the people in the study? 
0 0.5 0.5 1 
     
Do the results include how indeterminate results, missing 
results and outliers of the index test were handled? 
0 1 1 0 
     
Do results include criteria for defining severity of the 
target disorder? 
0 0 1 1 
     
Do the results include cross-tabulation of the index test 
results by the reference standard results? Or is there 
enough information to generate this? 
1 0 0 1 
     
Do the results include estimates of diagnostic test 
accuracy? 
0 1 1 0 
     
Do the results include important psychometrics?     
Inter-rater reliability 1 0.5 0 0 
Test-retest reliability 1 0 0 0 
Internal consistency 0 0 1 0 
Convergent validity 0 0 1 1 
Correlation with participant characteristics 0 0 1 0 
     
TOTAL 13.5 14 18.5 (ADOS) 
17.5 (ADI-R) 
15.5 
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Aspects of study completed jointly 
 All planning of study methodology. 
 Liaison with the ASD clinics from which recruitment took place. 
 Writing the project protocol. 
 Writing the NHS REC application. 
 Attendance at the NHS REC panel interview. 
 Recruitment of the non-clinical control group (n=22 completed by 
McKenner, n=5 completed by Clarke). 
Aspects of study completed by Kiri Clarke 
 All liaison with the IAPT services from which participants were recruited to 
the clinical control group. 
 Writing of NHS R&D applications relevant to the IAPT service and ASD 
services. 
 Recruitment and interviewing of IAPT participants for the clinical control 
group (n=8 recruited, n=7 interviewed). 
 Recruitment and interviewing of cases from ASD clinic (n=13). 
 Analysis and write-up of data for ASD group versus non-clinical control 
group. 
Aspects of study completed by Michele McKenner 
 All liaisons with the psychosis services and other non-IAPT services from 
which participants were recruited to the clinical control group. 
 Writing of the NHS R&D application relevant to the above services 
 Writing of a substantial amendment relevant to recruitment of psychosis 
participants. 
 Recruitment and interviewing of non-IAPT participants included in clinical 
control group (n=8), plus interviewing of one IAPT participant. 
 Analysis and write-up of data for ASD group versus clinical control group. 
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APPENDIX 4 
Letter of approval from National Research Ethics Service Committee  
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APPENDIX 5 
Sample information sheets  
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APPENDIX 6 
Sample consent forms  
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APPENDIX 7 
Invitation letter for historical ASD group cases  
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